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Abstract 
Guided tissue regeneration (GTR) to regenerate periodontal tissue involves placement of 
a cell-occlusive barrier membrane functionally excluding the gingiva and associated oral 
epithelium from the periodontal defect.  Gingival connective tissue contains a rich 
vascular plexus and is a source of progenitor cells which could contribute to periodontal 
regeneration.  We have investigated the use of a novel bioresorbable and bioactive 
electrospun fibrous polycaprolactone (PCL) scaffold loaded with microspheres releasing 
basic fibroblast growth factor (bFGF) to promote gingival connective tissue growth while 
maintaining a barrier to the oral epithelium.  Scaffolds supported an increase in human 
gingival fibroblast cell number and mesenchymal cell infiltration in a bFGF dose 
dependent manner while excluding oral epithelial cell penetration.  Scaffold treatment 
during early healing of rat gingival wounds showed good biocompatibility.  This study 
suggests that PCL electrospun scaffolds both with and without bFGF microspheres 
represent a promising alternative to the current generation of GTR barrier membranes. 
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Chapter 1  
1 Introduction 
1.1 Chapter Summary 
Periodontal diseases are pathologies which affect the tissues supporting teeth and are 
highly prevalent, affecting up to 90% of the world’s population (Pihlstrom, Michalowicz 
et al. 2005).  These supporting tissues are collectively termed the periodontium and 
function as a unit to securely anchor each tooth into the jaw.  The periodontium is 
composed of four tissues; the gingiva, the periodontal ligament (PDL), cementum and the 
alveolar bone (AAP 2001).  Periodontitis, often known as “gum” disease, is a severe, 
progressive inflammatory disease in which all of the tissues of the periodontium are 
negatively affected.  This condition is characterized by plaque formation, a loss of 
connective tissue attachment to the tooth, formation of a periodontal pocket and 
degeneration of the PDL, cementum and alveolar bone which, if left untreated, can lead 
to tooth loss (AAP 2001, Pihlstrom, Michalowicz et al. 2005).  Periodontitis is a 
significant healthcare burden as it is estimated that over 47% of the adult US population 
has periodontitis (Eke, Dye et al. 2012).  Treatments aimed at removing the causative 
bacterial agents are successful at halting the progression of the disease, but due to the 
limited capacity of the periodontium for self-repair, usually result in minimal 
regeneration of the lost tissues and can leave the patient with severe gingival recession 
(Hughes, Ghuman et al. 2010).  Therapeutic interventions such as guided tissue 
regeneration (GTR) have been devised to attempt to regenerate the lost periodontal 
structures.  
GTR is a technique in which an occlusive barrier membrane is placed under the gingiva 
over the tooth root to functionally exclude the gingival connective tissue and epithelium 
from contacting the root thus providing the periodontal ligament and alveolar bone a 
space into which they can regenerate (Nyman, Gottlow et al. 1982).  Occlusive 
membranes do not result in predictable or full regeneration of the lost periodontal 
structures, indicating that significant improvements can be made (Bartold, McCulloch et 
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al. 2000, Hughes, Ghuman et al. 2010).  In addition, occlusive membranes exclude the 
gingival connective tissue from the defect site.  This is problematic as the gingival 
connective tissue is a rich source of vasculature and contains progenitor cell populations 
which can contribute to periodontal regeneration (Schroeder and Listgarten 1997, 
Fournier, Larjava et al. 2013).    
The overall focus of this work is the testing of a fibrous bioactive and bioresorbable 
scaffold to recruit cells from the gingival connective tissue while maintaining a barrier to 
oral epithelial cells.  Electrospinning is a process that efficiently creates fibrous scaffolds 
which are ideal for use in tissue regenerative applications due to their high surface area to 
volume ratio and interconnected porosity allowing for cell infiltration and exchange of 
nutrients and waste products throughout the construct (Dong, Liau et al. 2009).   
Polycaprolactone (PCL) is a bioresorbable aliphatic polyester which can be electrospun 
into a fibrous matrix and is advantageous for use due to its low cost, abundance, long 
degradation time and biocompatibility (Dong, Liau et al. 2009).  To confer bioactivity to 
the scaffolds and promote in situ periodontal regeneration, basic fibroblast growth factor 
(bFGF) will be added to the scaffold during the electrospinning process by 
simultaneously electrospraying microspheres into the construct.  The microspheres have a 
core-shell structure with bFGF stabilized by heparin as the core encapsulated by a poly 
(lactide-co-glycolide) (PLGA) shell allowing for sustained release of the growth factor 
(Guo, Elliott et al. 2012).   
bFGF is capable of stimulating the proliferation of fibroblast cells in a dose-dependent 
manner, promoting angiogenesis, and accelerating oral wound healing (Gospodarowicz 
1974, Murakami, Takayama et al. 2003, Oda, Kagami et al. 2004, Murakami and Simons 
2008, Kitamura, Akamatsu et al. 2011).  We hypothesize that scaffolds fabricated by 
electrospinning the biocompatible polyester PCL into a fibrous scaffold loaded with 
microspheres containing bFGF will promote gingival fibroblast proliferation while 
maintaining a barrier to oral epithelial cells and promote the healing of full-thickness 
gingival wounds in a rat model.   
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1.2 The Periodontium 
1.2.1 Structure and Function 
The periodontium encompasses all of the structures that anchor teeth into the jaw.  The 
periodontium is comprised of both soft and hard connective tissues each of which plays a 
critical role in the structural and functional maintenance of tooth attachment and function.  
The periodontium is made up of four functional tissue components; the gingiva 
(commonly referred to as gums), the periodontal ligament (PDL), the alveolar bone and 
cementum (Bartold, Walsh et al. 2000) (Figure 1.1).   Each of these tissues is unique in 
terms of extracellular matrix (ECM) and cellular composition.  
The primary support for the tooth is provided by bone, with each tooth anchored into the 
jaw in a socket of mineralized alveolar bone through the PDL.  The alveolar bone is made 
up of an outer compact bone layer with an interior cancellous bone portion 
(Hammarstrom and Lindskog 1985).  The osteoblasts (bone forming cells) secrete the 
organic bone matrix, termed osteoid, which is primarily type I collagen (Piperni, 
Takamori et al. 2014).  The secreted matrix is calcified and the resulting bone is 60% 
inorganic material by weight with crystalline hydroxyapatite being the most abundant 
inorganic constituent (Feng 2009). Bone remodeling occurs through the highly regulated 
and coordinated actions of the bone depositing osteoblasts and the bone resorbing 
osteoclasts (Charles and Aliprantis 2014).   
The periodontal ligament is a dense connective tissue that forms the functional 
attachment between the mineralized tissues of the cementum and the alveolar bone. 
During mastication, the forces loaded on the teeth are dispersed through the PDL (Ho, 
Marshall et al. 2007).  The principle cell type of the PDL is the fibroblast which is found 
in a matrix of principal fibers (large bundles of type I collagen that traverse the PDL and 
are embedded in the bone and cementum) (Cho and Garant 2000).   In addition, the PDL 
matrix contains several small leucine rich proteoglycans (SLRPG) associated with the 
collagen fibril bundles, including lumican, fibromodulin, decorin, and biglycan 
(Matheson, Larjava et al. 2005).  
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Figure 1.1 - Anatomy of the periodontium. 
Periodontium refers to the tissues which are critical in attaching teeth to the jaw. A) 
Schematic illustrating a cross sectional view of a tooth and surrounding tissue. Tissues of 
the periodontium are labelled in blue and are shown in reference to the tooth.  B) 
Hematoxylin and eosin stained section of a rat molar and surrounding tissue. The tissues 
of the periodontium are labelled as periodontal ligament (PDL), cementum (C), alveolar 
bone (B) and the gingiva which is composed of connective tissue (CT) covered by oral 
epithelium (OE).  The gingiva attaches to and forms a tight seal with the tooth through 
the junctional epithelium (JE) which merges with the sulcular epithelium (SE) in the 
gingival sulcus. The tooth is composed of dentin (D) with an enamel crown, shown as an 
enamel space (E) in histologic sections.  The cementoenamel junction (CEJ) is a 
landmark feature where the cementum covering the tooth root (R) meets the enamel.  
Terminology regarding directionality associated with the tooth is such that coronal 
indicates towards the crown of the tooth and apical indicates towards the apex of the root.   
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Cementum is a thin layer of mineralized tissue found on the surface of the dentinal tooth 
root where the tooth root interfaces with the PDL (Foster 2012).  Cementum functions to 
anchor the collagen fiber bundles of the PDL to the tooth root through structures termed 
Sharpey’s fibers (Bosshardt and Selvi 1997).  The organic component of cementum is 
mainly type I collagen (>90%) with approximately 5% type III collagen (Birkedal-
Hansen, Butler et al. 1977) and is formed by cementoblasts which are derived from 
neural crest cells during development (ectomesenchymal origin) (Chai, Jiang et al. 2000).   
The gingiva is composed of a type I collagen rich dense connective tissue with an 
overlying epithelium and forms a soft connective tissue covering over the PDL, alveolar 
bone, cementum, and tooth roots.  Oral gingival epithelial cells (ectodermal origin) are 
the main cell type of the epithelium; however, other cells may be seen such as 
Langerhans cells, melanocytes and Merkel cells (Ramibri, Panzica et al. 1992, Barrett 
and Raja 1997, Bartold, Walsh et al. 2000).  The epithelium of the gingiva is divided into 
three distinct anatomical regions which differ in their cellular organization, function and 
keratin composition (Mackenzie, Rittman et al. 1991).  These regions are defined as the 
oral gingival, oral sulcular and junctional epithelia (Schroeder and Listgarten 1997).  
Overall, the epithelia functions to prevent bacterial infiltration into the underlying 
periodontium.  The teeth present a unique challenge to this protective function in that the 
tooth is not an appendage of the mucosa, but rather perforates through it.  Thus, a tight 
seal must be made between the hard tissue of the tooth and the epithelium of the gingiva.  
This occurs through the junctional epithelium which attaches to the tooth from the 
cementoenamel junction to the bottom of the gingival sulcus (Bosshardt and Lang 2005).  
The junctional epithelium is a stratified, non-keratinizing epithelium which is bordered 
by two basal lamina; an external basal lamina found between the epithelium and the 
connective tissue and an internal basal lamina found between the epithelium and the 
surface of the tooth (Sawada and Inoue 1996, Bosshardt and Lang 2005).  The connective 
tissue component of the gingiva is composed of gingival fibroblasts (mesenchymal 
origin) residing within an extracellular matrix of collagen, mainly type I, and 
proteoglycans including decorin, biglycan, versican, and CD44 (Bratt, Anderson et al. 
1992, Larjava, Hakkinen et al. 1992, Hakkinen, Oksala et al. 1993).  Collagen fibers of 
the matrix show considerable organization into thick bundles and form the gingival 
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supra-alveolar fiber apparatus which attaches to the tooth (Chavrier, Couble et al. 1984, 
Bartold, Walsh et al. 2000).  Together, the connective tissue and epithelium maintain 
homeostasis of the periodontium by functionally excluding the oral environment from the 
underlying structures.  The integrity of the barrier can however be compromised 
following injury, trauma or prolonged poor oral hygiene which then allows for invasion 
of the tissues by microbial organisms (Schroeder and Listgarten 1997). 
1.2.2 Periodontal Diseases 
Periodontal diseases are broadly defined as pathologies that affect the periodontium. 
These conditions can be inherited, but are usually acquired.  Furthermore, periodontal 
diseases are influenced by genetic, traumatic, developmental or inflammatory factors 
(Pihlstrom, Michalowicz et al. 2005). However, the term periodontal disease is most 
commonly used to refer to the inflammatory conditions in which inflammation of the 
periodontium is caused by pathogenic bacteria in tooth plaque that accumulates on and 
around the tooth surfaces (Armitage 2004, Pihlstrom, Michalowicz et al. 2005).  
Periodontal diseases range in severity with the mildest form being gingivitis.  Gingivitis 
is mild inflammation that is confined to the gingiva and can be readily reversed by 
removing the causative bacterial agents through routine oral hygiene (Pihlstrom, 
Michalowicz et al. 2005).  Although reversible, gingivitis is highly prevalent with more 
than 82% of adolescents and 50% of adults in the United States being affected (Albandar 
and Rams 2002).  If gingivitis is allowed to persist, the condition progresses and can 
develop into the more serious periodontitis (Albandar and Rams 2002).   
Periodontitis affects all of the structures of the periodontium and leads to destruction of 
the gingival connective tissue and the PDL, and resorption of the alveolar bone, which 
can lead to loosening of the tooth and eventual tooth loss (AAP 2001, Pihlstrom, 
Michalowicz et al. 2005).  Periodontitis develops when bacterial components and their 
products which have accumulated around the teeth infiltrate the gingival epithelium into 
the connective tissue and cause a persistent host inflammatory response (Page, 
Offenbacher et al. 1997).  The tight seal maintained by the junctional epithelium is 
compromised, exposing the underlying periodontium to the more than 500 bacterial 
species present in the oral cavity (Moore and Moore 1994, Bosshardt and Lang 2005).  
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The loss of connective tissue attachment results in the formation of a periodontal pocket 
which becomes lined with gingival epithelium and further accumulates bacteria and 
plaque (Page, Offenbacher et al. 1997).   The pathogenesis is, in part, mediated through 
bacterial release of endotoxins and proteases which break down the tissues of the 
periodontium (Socransky and Haffajee 1994).  Of even greater significance is that the 
persistence of bacteria activates the host immune inflammatory response, and if 
sustained, will result in release of proteolytic enzymes which further contribute to tissue 
breakdown (Pihlstrom, Michalowicz et al. 2005).  During the inflammatory response, 
macrophages become activated and release several factors including interleukin 1β, 
tumour necrosis factor α, matrix metalloproteinases, and prostaglandin E2 (Page, 
Offenbacher et al. 1997).  Gingival fibroblasts are activated to produce matrix 
metalloproteinases and prostaglandin E2 in response to interleukin 1β and tumour 
necrosis factor α (Page, Offenbacher et al. 1997).  Matrix metalloproteinases mediate the 
destruction of the extracellular matrix components and prostaglandin E2 mediates 
resorption of the alveolar bone (Page, Offenbacher et al. 1997).   
Periodontitis has a high prevalence rate. Data from the 2009 and 2010 National Health 
and Nutrition Examination Survey estimated that 47% of the adult U.S. population is 
affected by periodontitis (Eke, Dye et al. 2012).  Several factors predispose an individual 
to being affected by periodontal diseases including: poor oral hygiene, tobacco use, 
stress, diabetes, and age (Petersen and Ogawa 2005, Kinane, Bouchard et al. 2008).  
Periodontitis can also have interactions with other systemic conditions.  Clinical studies 
suggest that periodontitis is more severe in patients with uncontrolled diabetes mellitus 
and can negatively impact cardiovascular events in susceptible individuals due to the high 
inflammatory burden associated with periodontitis (Kinane, Bouchard et al. 2008).   
In addition to its high prevalence rate, the major concern with periodontitis is the limited 
ability of the periodontium to regenerate even after removal of the causative bacterial 
agents (Pihlstrom, Michalowicz et al. 2005, Hughes, Ghuman et al. 2010).  Non-surgical 
treatment of periodontitis involves the removal of plaque and bacteria from around the 
tooth, however this only serves to stop the progression of the disease with little 
appreciable regeneration of the lost structures (Pihlstrom, Michalowicz et al. 2005, 
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Hughes, Ghuman et al. 2010).  Following treatment, inflammation and swelling of the 
gingival tissue subsides, but apical migration of the epithelium and tissue shrinkage result 
in gingival recession (Tugnait and Clerehugh 2001).   
When the gingival margin is located apical to the normal location at the cementoenamel 
junction, gingival recession is diagnosed (AAP 2001). In addition to being caused by 
periodontitis, gingival recession can be a result of trauma, poor tooth alignment, or 
thinning or reduction of the alveolar bone (Watson 1984, Chambrone and Chambrone 
2003).  Gingival recession can also affect individuals with good oral hygiene; a 
prevalence rate of 25% was evident in a sample population who had good oral hygiene 
and received regular dental care (Seritm, Wennstrom et al. 1994).  The prevalence of 
gingival recession is high, with more than 50% of the population having at least one site 
of gingival recession (Kassab and Cohen 2003).  Gingival recession may be present 
without being apparent to the patient, however other patients with recessions may 
experience pain and root hypersensitivity, fear over tooth loss, and esthetic concerns 
(Kassab and Cohen 2003).   Exposure of the tooth root to the oral cavity due to gingival 
recession causes tooth sensitivity and may make the root more susceptible to abrasion 
and caries which is damaging to the health and survival of the tooth (Kassab and Cohen 
2003).  Gingival recession resultant from periodontitis indicates that the healing response 
is inadequate to restore the correct functional and anatomical structure of the 
periodontium.   
1.3 Gingival Wound Healing 
1.3.1 Connective Tissue  
The basic stages of wound healing that take place during cutaneous wound repair also 
occur during healing of the oral mucosa. Three sequential, but overlapping, phases of 
wound healing are required: inflammatory phase, granulation tissue formation and matrix 
deposition and remodeling (Wikesjo and Selvi 1999).  Immediately following connective 
tissue injury, plasma proteins from the blood, primarily fibrinogen, adhere to wound 
surfaces and the tooth root in preparation for the formation of a fibrin clot (Wikesjo and 
Selvi 1999, Polimeni, Xiropaidis et al. 2006).   Within hours of injury, a pro-
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inflammatory response is initiated, characterized by infiltration of neutrophils and 
monocytes to phagocytose cellular debris from the damaged and necrotic areas of the 
tissues (Polimeni, Xiropaidis et al. 2006).  Up to three days following injury, 
inflammation persists with neutrophil infiltration gradually subsiding as macrophage 
influx becomes predominant. The phenotype of the macrophages switches to promote 
repair through the release of growth factors such as transforming growth factor-β1 (TGF-
β1) which enables the transition to development of granulation tissue and the proliferative 
stage of repair (Leibovich and Ross 1975, Wikesjo and Selvi 1999).  As granulation 
tissue forms up to day seven following injury, fibroblasts and endothelial cells migrate 
into the wound area and proliferate, a provisional matrix is deposited, and angiogenesis 
occurs (Wikesjo and Selvi 1999, Polimeni, Xiropaidis et al. 2006).  Fibroblast migration 
into the granulation tissue requires downregulation of integrins for collagen attachment 
(α2β1) and upregulation of integrins for interaction with components of the provisional 
matrix: fibrin (αVβ3), fibronectin (α4β1) and vitronectin (αVβ5) (Aukhil 2000).  
Following the events in the initial seven days post-injury, the wound enters the matrix 
remodeling phase wherein the granulation tissue matrix is remodeled into a more 
collagen rich, mature and stable matrix followed by the appearance of myofibroblasts 
which contract the wound (Wikesjo and Selvi 1999, Polimeni, Xiropaidis et al. 2006).  
Although the initial steps of wound healing are essentially analogous to most soft tissue 
healing, proper periodontal healing requires the connective tissue to make adequate 
adhesion to the tooth root through anchorage of collagen fibers to the cementum 
(Wikesjo and Selvi 1999).   
1.3.2 Epithelial Component 
Within hours of a gingival wound forming, basal epithelial cells start to proliferate and 
migrate into the fibrin clot in the wound area (Polimeni, Xiropaidis et al. 2006).  In 
uninjured tissue, basal epithelial cells are attached to the basal lamina through integrin 
α6β4 attachment to laminin (Aukhil 2000).  To initiate migration in response to injury the 
epithelial cells must first break hemidesmosome connections with the basal lamina and 
express integrins suitable for migration through the fibrin clot (Borradori and Sonnenberg 
1999, Aukhil 2000).  Migrating epithelial cells start to express integrins α5β1 
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(fibronectin), αVβ6 (tenascin), αVβ5 (vitronectin) and reorganize their distribution of 
integrin α2β1 (collagen) allowing for migration over wound debris and the provisional 
wound matrix (Aukhil 2000).  Migrating epithelial cells also upregulate tissue-type 
plasminogen activator and urokinase-type plasminogen activator which activate the 
plasminogen in the fibrin clot to plasmin allowing for the breakdown of the clot, thus 
creating a path through which migration can occur (Martin 1997).  Once the wound is re-
epithelialized a new basal lamina forms and epithelial cells return to their original 
phenotype (Aukhil 2000).  The epithelium must also reform the junctional and sulcular 
epithelium found adjacent to the tooth.  The junctional epithelium appears to be 
regenerated from undifferentiated cells from the sulcular epithelium (Sabag, Mery et al. 
1984).  Formation of a long junctional epithelium can occur following gingival wounding 
where the epithelium is found migrating apically along the tooth root hindering the 
formation of connective tissue attachment to the tooth root.  This occurs as a result of the 
epithelium migrating faster than the formation and attachment of new connective tissue to 
the tooth root (Bartold, Walsh et al. 2000). The formation of this periodontal pocket is 
one of the major problems in the regeneration of gingival connective tissue and must be 
prevented.    
Although the gingiva possesses considerable healing capacity following injury, repair 
following the repeated inflammatory response associated with inflammatory periodontal 
diseases results in tissue shrinkage, fibrosis and gingival recession (Hughes, Ghuman et 
al. 2010).  This in combination with the formation of a periodontal pocket prevents 
proper anatomical self-repair of the periodontium thus requiring periodontal therapeutic 
intervention (Pihlstrom, Michalowicz et al. 2005).  
1.4 Periodontal Disease Treatments 
1.4.1 Periodontal Plastic Surgery 
Periodontal plastic surgery refers to surgical techniques and procedures used to treat and 
correct several types of periodontal defects, including surgeries to correct gingival 
recession (Miller 1988).  There are several procedures which can be used to correct 
gingival recession defects, such as coronally advanced flaps, free gingival grafts, laterally 
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repositioned flaps and subepithelial connective tissue grafts (SCTGs) (Chambrone, 
Sukekava et al. 2010).  SCTGs are considered the gold-standard for the treatment of 
gingival recession defects (Chambrone, Chambrone et al. 2008, Chambrone, Sukekava et 
al. 2010).   In this procedure, a palatal donor site is raised and a connective tissue graft 
larger than the recession site is removed.  The flap created at the donor site must then be 
sutured back into place.  At the recipient site, a flap is raised with the harvested 
connective tissue graft placed over the exposed tooth root and sutured into place 
following cleaning of the root surface (Langer and Langer 1985, Raetzke 1985).  
Although considered the gold-standard, SCTG procedures are associated with several 
drawbacks mainly due to the need for a second surgical donor site. The donor site is 
associated with pain and discomfort, bleeding, morbidity, and the availability of donor 
tissue in the palate is extremely limited (Liu, Mao et al. 2011).  In addition, as oral 
epithelial tissue proliferates faster than connective tissue or graft tissue, it commonly 
migrates down the tooth root forming a long junctional epithelium and impairing the 
ability of the connective tissue or graft to attach and provide root coverage (Bartold, 
McCulloch et al. 2000).   
1.4.2 Guided Tissue Regeneration 
Guided tissue regeneration (GTR) is a technique that involves the placement of a barrier 
membrane into the periodontal defect site immediately under the gingival tissue forming 
a physical gap or barrier to exclude epithelium from populating the damaged site; 
maintaining space for the PDL and alveolar bone to regenerate into (Fu, Su et al. 2012) 
(Figure 1.2).  This technique was first introduced in 1982 when Nyman and colleagues 
(Nyman, Gottlow et al. 1982) used a Millipore filter as a membrane in a non-human 
primate model of periodontitis to regenerate periodontal structures and remains a 
routinely used surgery by periodontists. The use of barrier membranes for periodontal 
repair overcomes the drawbacks associated with SCTGs in that it does not rely on the 
availability of donor tissue.   
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Figure 1.2 - Guided tissue regeneration. 
We propose the use of a PCL electrospun fibrous scaffold membrane as an alternative to 
the current cell-occlusive GTR membranes.  Membranes are placed under the gingival 
connective tissue against the root of the tooth to prevent the apical migration of the oral 
epithelium.  To promote PDL cell infiltration and bone regeneration a second scaffold or 
material can be placed into the periodontal defect. 
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GTR membranes must fulfill certain characteristic properties including biocompatibility 
and safety, space maintenance, ease of use, and cell exclusion (Aurer and Jorgic-Srdjak 
2005).   The concept of space maintenance and cell exclusion is such that the gingiva is 
excluded from the defect site providing the periodontal ligament cells with a space 
adjacent to the tooth into which they can selectively repopulate the defect (Gottlow, 
Nyman et al. 1986).  As described below, several types of materials are used clinically as 
a barrier membrane. The types of membranes used can be classified into non-resorbable; 
those requiring surgical removal following periodontal regeneration, or resorbable; those 
which are degraded during the healing process.  Resorbable membranes can be fabricated 
from natural or synthetic materials, as discussed in detail in the following sections. 
1.4.2.1 Non-Resorbable Membranes - Gore-Tex® 
Non-resorbable membranes maintain their structure and integrity throughout the healing 
process, with the most commonly used material being Gore-Tex®. Gore-Tex® expanded 
polytetrafluoroethylene (ePTFE) membranes were the first non-resorbable membranes 
approved for clinical use (Aurer and Jorgic-Srdjak 2005).  ePTFE is manufactured from 
the inert and biocompatible fluorocarbon polymer polytetrafluoroethylene under tensile 
strength creating a porous and fibrous microstructured material (Aurer and Jorgic-Srdjak 
2005).  Although the use of these membranes show improvements in periodontal clinical 
parameters, complete regeneration remains a challenge (Gottlow, Nyman et al. 1986, 
Stahl, Froum et al. 1990, Kersten, Chamberlain et al. 1992, Wadhawan, Gowda et al. 
2012).  These occlusal membranes provide adequate space maintenance and cell 
exclusion in the defect site, but as they are non-resorbable, a second surgery is required to 
retrieve the membrane.  This is not ideal as it increases surgical time for the patient, 
increases the cost of the GTR procedure and adds additional surgical trauma to any newly 
formed periodontal tissue (Gottlow 1993). 
1.4.2.2 Biodegradable and Bioresorbable Membranes 
To eliminate the need for a second surgery to remove membranes following healing, 
resorbable membranes for periodontal regeneration were developed.  These membranes 
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act as a space making barrier during the healing period and following the establishment 
of new periodontal attachment the material degrades, ideally without affecting the 
regeneration of the periodontal tissues (Gottlow 1993).  While natural materials have 
been investigated for use as membranes, their biomechanical properties are not optimal 
for an active biomechanical environment where aggressive oral epithelial migration 
occurs. The material must have resilience and strength which membranes made from 
natural material rarely possess (Aurer and Jorgic-Srdjak 2005). Several synthetic 
biomaterials have now been developed for use as barrier membranes.  Synthetic polymers 
are an attractive option due to their low cost, abundance, ease of fabrication and large 
customization potential.  Polylactic acid (PLA), polyglycolic acid (PGA), PCL and their 
copolymers have been widely investigated.  These three polyesters have been approved 
by the U.S. Food and Drug Administration for use in medical applications such as 
bioabsorbable sutures and applications for drug delivery (Dong, Liau et al. 2009).  
1.4.2.2.1 Collagen 
Collagen membranes were developed for GTR applications due to their inherent 
biocompatibility and their chemotactic properties for fibroblasts (Postlethwaite, M. et al. 
1978, Rothamel, Schwarz et al. 2004), examples of which include: BioMend® and Bio-
Gide®.  Collagen membranes were found to support connective tissue attachment and 
prevent epithelial migration along the tooth root in canine periodontal defects 
(Blumenthal 1988, Pitaru, Tal et al. 1989) and were found to be as effective as ePTFE 
membranes at restoring clinical periodontal attachment in clinical studies (Blumenthal 
1988, Pitaru, Tal et al. 1989, Tatakis, Promsudthi et al. 1999).  The degradation of 
collagen membranes occurs through the enzymatic activity of inflammatory cells and 
degrade within 4-8 weeks (Blumenthal 1988, Pitaru, Tal et al. 1989, Tatakis, Promsudthi 
et al. 1999).  For effective space maintenance in the defect site the membrane must 
withstand the forces created by flap placement and associated with mastication (Tatakis, 
Promsudthi et al. 1999).  The failure of collagen membranes to withstand such forces, 
along with their rapid degradation in particular when exposed to enzymes associated with 
saliva and the inflammatory response may contribute to their variability in regenerating 
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periodontal tissue and the inability to promote complete periodontal defect fill (Pitaru, Ta 
et al. 1987, Bunyaratavej and Wang 2001).   
1.4.2.2.2 Polylactic Acid 
PLA is a synthetic poly (α-hydroxy acid) which is manufactured by catalytic 
polymerization of lactic acid monomers (Tatakis, Promsudthi et al. 1999).  In contrast to 
collagen which degrades by enzymatic activity, poly (α-hydroxy acids) are degraded by 
hydrolysis with the resulting degradation products being metabolized by the citric acid 
(Kreb) cycle to produce water and carbon dioxide (Tatakis, Promsudthi et al. 1999).  PLA 
hydrolysis is relatively slow and produces monomers of lactic acid, linear dimers and 
other oligomers (Marcato, Paganetto et al. 1996) which can be cytotoxic in high 
concentrations, although the polymers themselves are biocompatible in vitro (Ignatius 
and Claes 1996).  Although PLA is biocompatible in vitro, implantation into periodontal 
defects initiates an inflammatory response at 4 weeks (Wikesjö and Nilvéus 1990) and 
severe bone resorption was observed 4 months following implantation (Mau, Cheng et al. 
2012).  This suggests that PLA is not an ideal synthetic biomaterial for GTR membranes. 
1.4.2.2.3 Polyglycolic Acid 
PGA has a relatively fast degradation rate compared to other synthetic aliphatic 
polyesters (Dong, Liau et al. 2009).  PGA is used clinically for pins, screws, rods and 
implants in orthopedic applications.   PGA implants in bone are associated with localized 
inflammation which does not compromise repair, however this inflammatory response 
may be problematic when using PGA for soft tissue wound repair or regenerative 
applications where the tissue is already inflamed (Bostman, Hirvensalo et al. 1990, 
Ceonzo, Gaynor et al. 2006).  Subcutaneous PGA polymer implants have been associated 
with an acute inflammatory response, the magnitude of which is proportional to the 
degradation time of the polymer, with faster degradation times inducing greater 
inflammatory responses (Burdick, Padera et al. 2002). As with PLA, high concentrations 
of the degradation products can be cytotoxic and damage surrounding tissue (Bostman, 
Hirvensalo et al. 1990, Ashammakhi and Rokkanen 1997, Ceonzo, Gaynor et al. 2006, 
Dong, Liau et al. 2009).  The inflammatory response to PGA may affect matrix 
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production and ultimately the integrity of the healing tissue (Kojima, Bonassar et al. 
2002).  To prolong the degradation time and make PGA more suitable in terms of 
providing adequate support for regenerating periodontal tissue and reducing the 
inflammatory response for membranous tissue repair applications, PGA is often 
combined with PLA to form the copolymer poly (lactide-co-glycolide) (PLGA) which 
has an intermediate degradation time between the two polymers.  Gingival fibroblasts 
cultured on PLGA membranes in vitro had decreased proliferation compared to gingival 
fibroblasts cultured on collagen membranes, indicating that collagen membranes may 
preferentially promote gingival tissue repair (Hakki, Korkusuz et al. 2013).   
Barrier membranes currently used for GTR that are completely occlusal do not work 
well.  As described above, the use of barrier membranes in periodontal procedures does 
not provide predictable or full regeneration of the damaged periodontium, making it clear 
that several improvements need to be made to the GTR technique (Kersten, Chamberlain 
et al. 1992, Greenstein and Caton 1993, Ivanovski 2009, Hughes, Ghuman et al. 2010).  
Space provision by GTR membranes appears to be a requirement for facilitating 
periodontal regeneration, whereas tissue occlusion does not appear to be a necessity 
(Wikesjo, Lim et al. 2003, Polimeni, Albandar et al. 2005).  The use of an occlusive 
membrane which excludes gingival connective tissue from a regenerating periodontal 
defect is less than ideal as the gingiva contains a rich vascular plexus and is a potential 
source of progenitor cells (Schroeder and Listgarten 1997, Fournier, Larjava et al. 2013).  
A new generation of biomaterials needs to be developed and investigated for improved 
GTR.  One potential improvement is developing a fibrous, selectively occlusive 
biomaterial scaffold membrane as an alternative to the current occlusal barrier 
membranes.   
1.4.3 Scaffold Membrane-Mediated Periodontal Regeneration 
Scaffold membrane-mediated tissue regeneration is a strategy that is focused on 
promoting regeneration of the normal tissue architecture to restore tissue function 
through the use of a specifically designed biomaterial scaffold.  This technique uses 
biocompatible, resorbable biomaterial scaffold membranes fabricated to act as a 
supportive three dimensional matrix, as opposed to cell-occlusive barrier membranes 
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used currently for GTR.  Ideally these scaffolds can mimic the natural fibrous structure of 
the ECM, facilitating cell attachment and subsequent infiltration to promote the formation 
of a functional cellular and vascular connective tissue attachment to the tooth root while 
acting as a barrier for unfavourable cells, specifically epithelial cells (Schroeder and 
Listgarten 1997, Sun, Qu et al. 2012).  The scaffolds can also be engineered to 
incorporate growth factors that allow for their controlled and sustained release in the 
defect site (Kaigler, Cirelli et al. 2006, Barnes, Sell et al. 2007, Kao, Murakami et al. 
2009).   
Several scaffold materials have been tested for periodontal tissue healing applications 
(Nakahara, Nakamura et al. 2003, Mohammadi, Shokrgozar et al. 2007, Jansen, Kuijpers-
Jagtman et al. 2008, Ayvazyan, Morimoto et al. 2011, Lotfi, Shokrgozar et al. 2011).   
Collagen scaffolds were shown to be biocompatible in palatal wound healing applications 
(Jansen, Kuijpers-Jagtman et al. 2008, Ayvazyan, Morimoto et al. 2011); however, due to 
the requirement for mechanical stability in periodontal defects collagen scaffolds are not 
ideal.  Chitosan scaffolds, created by alkaline deacetylation of chitin (Akncbay, Senel et 
al. 2007), and collagen scaffolds seeded with gingival fibroblasts increased the width of 
keratinized gingival tissue in a canine model and in a clinical setting, respectively 
(Mohammadi, Shokrgozar et al. 2007, Lotfi, Shokrgozar et al. 2011).   This method, 
however, requires a separate initial surgery for the harvesting of gingival fibroblasts and 
requires ex vivo culture of the cells thus increasing the time, cost, and complexity of such 
a procedure (Sun, Qu et al. 2012).  Advances in the field of materials engineering make it 
possible to design biofunctional biomaterial scaffolds which can be used to recruit 
endogenous cells surrounding the defect site to promote in situ periodontal tissue 
regeneration (Sun, Qu et al. 2012), which is the focus of this thesis.   
1.4.3.1 Scaffold Fabrication 
Development of optimal scaffolds requires: 1) selection of the appropriate material, 2) 
fabrication of the appropriate structural architecture, and 3) addition of appropriate 
biological signals, such as growth factors.  Synthetic polyesters have been widely studied 
for use in biomaterial scaffolds due to their availability and abundance, ease of 
fabrication, customizability in terms of strength and degradation rate, and their 
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biocompatibility and biodegradability characteristics.  One particularly attractive property 
of synthetic polymers is that they can be electrospun to create structures similar in size to 
native ECM.  
1.4.3.2 Electrospinning 
Electrospinning is a process which can be used to fabricate fiber-based constructs from 
both natural and synthetic polymers.  The polymer is dissolved in a solvent and the 
resulting solution is charged.  A collection plate is oppositely charged and the polymer 
solution is drawn into fibers by static electricity.  As the solvent evaporates, the solid 
polymer fibrous structure is left behind (Kumbar, James et al. 2008).  This technique 
allows fabrication of scaffolds which closely mimic the fibrous nature of the ECM.  The 
fibers produced by electrospinning are non-woven and have an interconnected porosity 
allowing for cells to interact with the fibers while permitting cell infiltration throughout 
the porous scaffold network and maintaining nutrient and waste exchange within the 
scaffold (Dong, Liau et al. 2009).  
The process of electrospinning has several advantages over other methods for scaffold 
fabrication such as phase separation and self-assembly.  Electrospinning is able to be 
carried out in the laboratory setting but is scalable and can be adapted to large scale 
processing, it is cost effective, convenient, and the diameter and alignment of the fibers is 
able to be manipulated (Murugan and Ramakrishna 2007).  The electrospinning apparatus 
can also be set up to produce different nanofibrous structures such as aligned nanofibers, 
tubular structures, and core-shell structures (Dong, Liau et al. 2009).   
Several natural and synthetic materials have been electrospun into fibrous scaffolds.  
Natural materials which have been electrospun include collagen, chitosan, agarose, and 
alginate (Matthews, Wnek et al. 2002, Bhattarai, Edmondson et al. 2005, Shu-Hua Teng, 
Peng Wang et al. 2009, Bonino, Krebs et al. 2011).  Although these materials are capable 
of being electrospun into fibrous scaffold membranes, their weak mechanical properties 
and short degradation time limit their use for GTR membrane applications where they are 
required to withstand the tissue tension forces associated with flap placement following 
surgery and forces transmitted through the flaps from mastication (Tatakis, Promsudthi et 
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al. 1999, Li, Laurencin et al. 2002, Teo, He et al. 2006).  Synthetic polymers offer greater 
mechanical stability compared to natural polymers.  Synthetic polymers which have been 
electrospun include PLA, PGA, and PCL and their copolymers (Huang, Zhang et al. 
2003).   
1.4.3.3 Polycaprolactone 
PCL is a bioresorbable, aliphatic polyester with a molecular weight of 80,000 and a 
relatively long degradation time compared to other synthetic polyesters, making it 
suitable for space provision in GTR applications (Lam, Hutmacher et al. 2009).  PCL is 
quite stable during in vitro hydrolysis testing however shows a faster degradation rate by 
microorganisms and enzymes (Zeng, Chen et al. 2004, Dong, Liau et al. 2009).  The 
degradation of PCL occurs in two stages.  The first is non-enzymatic bulk hydrolysis in 
which the carboxylic acid end groups autocatalyze the hydrolysis of the ester linkages 
decreasing the molecular weight of the polymer without a decrease in weight 
(Woodward, Brewer et al. 1985).  Once the molecular weight of the polymer decreases to 
5,000 weight loss occurs as the oligomeric species produced become small enough to 
diffuse away from the bulk polymer (Woodward, Brewer et al. 1985).  In the second 
stage, low molecular weight PCL particles are ingested by neutrophils, macrophages, 
giant cells and to a lesser extent, fibroblasts in vivo (Woodward, Brewer et al. 1985).   
PCL fibrous scaffolds were found to have a faster degradation rate in vivo compared to in 
vitro with smaller diameter fibers degrading faster than larger diameter fibers (Bölgen, 
Menceloglu et al. 2005).  Implantation of PCL scaffold matrices in both intramuscular 
and subcutaneous sites were found to be biocompatible and did not elicit a negative host 
response at 3 and 6 months post implantation (Lam, Hutmacher et al. 2009).  This is in 
contrast to the inflammatory response observed with PLA and PGA membranes, as 
mentioned previously.  Due to its long degradation time and biocompatibility, we 
hypothesize that PCL is an appropriate material for fabrication of electrospun fibrous 
scaffolds for periodontal regenerative applications.  While fibrous PCL scaffolds can be 
made to mimic the structural architecture of the ECM, this polymer lacks bioactivity, 
which can impair tissue response. 
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1.4.3.4 Enhancing Scaffold Bioactivity 
Growth factors play important roles in the wound healing process, including the induction of 
cell migration, proliferation and differentiation. Several studies have found the delivery of 
growth factors to periodontal defect sites to be advantageous and promote regeneration 
(Howell, Fiorellini et al. 1997, Oda, Kagami et al. 2004, Nemcovsky, Zahavi et al. 2006, Fu, 
Su et al. 2012). The application of growth factors has had limited clinical success, due to the 
rapid diffusion and degradation of topically applied growth factors, their short half-lives, and 
the need to be administered in large doses (Kaigler, Cirelli et al. 2006, Hughes, Ghuman et al. 
2010). There is a clear need for a more sustained method of delivery.  Our aim is to create a 
bioactive PCL electrospun fibrous scaffold that can be used for applications in periodontal 
regeneration.  
1.4.3.4.1 Electrospraying Core-Shell Microspheres 
To confer bioactivity to the PCL electrospun fibrous scaffolds growth factors will be 
delivered in the form of core-shell structured microspheres loaded into the fibrous 
structure of the scaffold.  Incorporation of growth factors into the scaffolds using this 
method will allow for controlled and temporally sustained release of the growth factor.  
Core-shell structures are produced by a coaxial electrospraying process wherein two 
streams of materials are combined; an inner nozzle, containing the core material solution, 
and an outer nozzle containing the shell material solution (Hwang, Jeong et al. 2008).  
Coaxial electrospraying can create uniform sized microspheres with an outer polymer 
shell and inner colloid core (Hwang, Jeong et al. 2008).  As the outer shell material 
degrades the inner core material is released in a controlled and sustained manner (Wu, 
Liao et al. 2010).  By combining the electrospraying and electrospinning processes, the 
microspheres can be uniformly distributed within the scaffold (Guo, Elliott et al. 2012).  
Due to its relatively fast degradation rate and biocompatibility when used in moderation, 
PLGA was chosen as the material for the shell structure. 
1.4.4 Biological Agents for Periodontal and Gingival Repair 
Several growth factors have been investigated for use in periodontal tissue repair, 
including platelet derived growth factor (PDGF), transforming growth factor-β1 (TGF-
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β1) and bone morphogenetic protein-2 (BMP-2).  While PDGF and TGF-β1 do stimulate 
the proliferation of gingival fibroblasts (Dennison, Vallone et al. 1994), the effect of 
TGF-β1 in particular on gingival tissue may promote fibrosis and scar formation (Raja, 
Byakod et al. 2009, Thompson, Hamilton et al. 2010).  BMP-2 is strongly osteogenic, 
however it is less than ideal for use due to its high cost, potential to cause root resorption 
and ankyloses and its cytotoxic effects on PDL cells (Wikesjo, Guglielmoni et al. 1999, 
Ryoo, Lee et al. 2006, Muthukuru 2013).  For these reasons and those listed below, we 
have focused our research program on bFGF.  Murakami and colleagues (Murakami, 
Takayama et al. 1999, Murakami, Takayama et al. 2003) were able to regenerate 
periodontal structures in beagle dogs with experimentally induced periodontitis following 
topical application of recombinant bFGF.  Topical application of bFGF was assessed in a 
large phase II clinical trial and found to be effective at regenerating the alveolar bone of 
patients with periodontitis, however did not result in gain of clinical attachment 
compared to vehicle alone (Kitamura, Akamatsu et al. 2011).  Since bFGF is a potent 
mitogen of mesenchymal cells and promotes wound healing, as described below, we 
hypothesize that the sustained release of bFGF from PCL electrospun GTR scaffolds will 
be effective at promoting the regeneration of clinical attachment. 
1.5 Basic Fibroblast Growth Factor 
1.5.1 General Structure and Function 
Basic fibroblast growth factor was first identified in brain and pituitary extracts based on 
its effects on the proliferation of 3T3 fibroblast cells (Gospodarowicz 1974).  Human 
bFGF was initially thought to be synthesized as a 155 amino acid protein which shares a 
high degree of sequence homology (98.7%) with bovine bFGF indicating that it is highly 
conserved across species (Abraham, Whang et al. 1986).  Human bFGF is encoded by 
one gene (FGFB) mapped to chromosome 4 (Abraham, Whang et al. 1986, Mergia, Eddy 
et al. 1986).  bFGF has since been identified as an 18 kDa protein with several high 
molecular weight (HMW) (22-24 kDa) translational variants (Moscatelli, Joseph-
Silverstein et al. 1987, Florkiewicz and Sommer 1989).  Crystallographic analysis of the 
bFGF protein revealed that the structure is entirely composed of β-sheets (Zhang, 
Cousens et al. 1991).  The tertiary structure of bFGF is composed of three 4-stranded β-
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meander motifs to create a barrel which is closed at the animo- and carboxy-terminus 
(Zhang, Cousens et al. 1991).  18 kDa bFGF is primarily found in the cytosol and 
increases cell growth and migration, whereas HMW bFGF is primarily localized to the 
nucleus and increases cell growth but not migration and is required for cell growth in low 
serum conditions (Renko, Quarto et al. 1990, Bikfalvi, Klein et al. 1995).   
In physiological systems, heparin or heparan sulfate proteoglycans protect bFGF from 
denaturation by binding to basic residues in the tenth and eleventh β strand of bFGF and 
are required for bFGF to activate fibroblast growth factor receptor (FGFR) tyrosine 
kinases (Rapraeger, Krufka et al. 1991, Kan, Wang et al. 1993, Nissen, Shankar et al. 
1999, Faham, Linhardtt et al. 1998).  Five FGFRs (FGFR 1-5) have been identified with 
bFGF binding with highest affinity to FGFR1 and FGFR2 (Mansukhani, Moscatelli et al. 
1990, Mansukhani, Dell'Era et al. 1992, Ornitz, Xu et al. 1996, Laestander and Engstrom 
2014).  Upon activation, FGFR tyrosine kinases dimerize and become 
autophosphorylated (Bellot, Crumley et al. 1991).  Several autophosphorylation sites in 
FGF receptor tyrosine kinase 1 (FGFR1) have been identified including Tyr-463, Tyr-
583, Tyr-585, Tyr-653, Tyr-654, Tyr 730 and Tyr-766 (Mohammadi, Dikic et al. 1996). 
Autophosphorylation of Tyr-766 causes association with phospholipase Cγ which 
catalyses the hydrolysis of phosphatidylinositol into diacylglycerol and free inositol 
phosphate which in turn activates protein kinase C to increase intracellular calcium, 
affecting cytoskeletal organization (Peters, Marie et al. 1992, Laestander and Engstrom 
2014).  Autophosphorylation on Tyr-653 and Tyr-654 is required for the biological 
activity of the receptor and may activate the Ras signaling pathway through 
phosphorylation of Shc or a 90 kDa protein (pp90) (Mohammadi, Dikic et al. 1996).   
Activated FGFR activates the docking protein FGFR substrate 2α which complexes with 
the adaptor protein Grb2, tyrosine phosphatase Shp2 and docking protein GAB1 
(Laestander and Engstrom 2014).  Guanine nucleotide exchange factor SOS binds to 
Grb2 and subsequently activates Ras-Mitogen activated protein kinase which through 
interaction with intracellular kinases and transcription factors ultimately results in 
regulation of gene expression, mainly with mitogenic effects (Laestander and Engstrom 
2014).   
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1.5.2 Angiogenesis 
bFGF is a potent modulator of angiogenesis.  Angiogenesis requires the migration of 
endothelial cells and bFGF is one of the regulators of the migration of several types of 
endothelial cells.  Endothelial cells synthesize bFGF and upregulate the synthesis and 
cytoplasmic stores during migration (Biro, Yu et al. 1994).  Prior to DNA synthesis, 
bFGF accumulates in the nucleus of endothelial cells (Biro, Yu et al. 1994).  Exogenous 
bFGF also plays a role in endothelial cell migration with the addition of bFGF to in vitro 
cultures enhancing migration and the addition of antibodies to bFGF inhibiting migration 
(Biro, Yu et al. 1994).   bFGF induces the expression of another potent angiogenic factor, 
vascular endothelial growth factor (VEGF), in endothelial cells through both autocrine 
and paracrine mechanisms (Seghezzi, Patel et al. 1998).   The angiogenic effects of bFGF 
in vivo are modulated through VEGF suggesting that bFGF acts upstream of VEGF in the 
process of angiogenesis (Seghezzi, Patel et al. 1998, Murakami and Simons 2008).   
1.5.3 Chemotaxis 
The formation of granulation tissue at a wound site requires the migration of fibroblasts 
from the surrounding tissue into the provisional matrix.  bFGF stimulates the chemotaxis 
of skin fibroblasts and granulation tissue fibroblasts in vitro (Buckley-Sturrock, 
Woodward et al. 1989).  bFGF has been shown to promote the migration of fibroblasts 
through the phosphoinositide 3-kinase (PI3-Kinase)-Rac1-JNK pathway (Kanazawa, 
Fujiwara et al. 2010).  Transfection of NIH 3T3 fibroblasts with bFGF cDNA increased 
migration and the addition of antibodies to bFGF inhibited migration, indicating that 
bFGF plays a role in fibroblast migration and the effect is mediated in part through 
autocrine bFGF secreted into the extracellular space (Mignatti, Morimoto et al. 1991, 
Mignatti, Morimoto et al. 1992).   
1.5.4 Mitogenic Effects 
Fibroblast proliferation is essential during wound healing. Expression of bFGF cDNA in 
mouse BALB/c 3T3 fibroblast mouse cells induced the growth of these cells compared to 
non-transfected parental cells (Sasada, Kurokawa et al. 1988).  bFGF is mitogenic for 
skin fibroblasts and granulation tissue fibroblasts (Buckley-Sturrock, Woodward et al. 
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1989).  In addition, during periodontal wound healing a new functional epithelial seal 
must form, and bFGF has been shown to stimulate the proliferation of gingival epithelial 
cells, with the effect being moderately attenuated in the presence of serum (Takayama, 
Yoshida et al. 2002).   
1.5.5 Role of bFGF in Wound Healing 
The importance of bFGF in wound healing is evident from studies using bFGF knockout 
mice.  Although the mice are viable, survive to adulthood and have no visible 
abnormalities, when injured, these mice show a significant decrease in the rate of skin 
healing (Ortega, Ittmann et al. 1998).  Furthermore, the addition of bFGF to wounds 
accelerates the rate of wound healing (Ribatti, Nico et al. 1999, Akita, Akino et al. 2008, 
Tan, Xiao et al. 2008).  Topical application of bFGF to experimentally created rat palatal 
wounds was found to accelerate the formation of granulation tissue and 
reepithelialization of the wound with an observed increase in basal epithelial cell 
proliferation (Oda, Kagami et al. 2004).   
bFGF is known to have effects at several different stages of wound healing.  During the 
inflammatory phase of wound healing, monocytes secrete growth factors to resolve the 
wound and stimulate the formation of granulation tissue (Wahl, Wong et al. 1989).  
Monocytes in the wound area are converted to macrophages and secrete several growth 
factors including platelet derived growth factor, interleukin-1, tumour necrosis factor and 
bFGF which act upon fibroblasts in the healing wound (Mahdavian Delavary, van der 
Veer et al. 2011).  Angiogenesis is a key event in wound repair and involves the 
migration of endothelial cells from existing vasculature into the wound space.  bFGF 
primes endothelial cells for angiogenesis and alters the expression of integrins allowing 
for migration into the wound bed (Klein, Giancottiti et al. 1993).  The final stage of 
wound repair is characterized by remodeling of the collagen matrix to produce a 
functional connective tissue.  Apoptosis of myofibroblasts is required for wound 
resolution and bFGF has been shown to play a role in the apoptosis of myofibroblasts in 
vitro (Funato, Moriyama et al. 1997) and in vivo during palatal wound healing (Funato, 
Moriyama et al. 1999).  bFGF downregulates collagen synthesis in normal skin 
fibroblasts and stimulates the production of the collagen digesting enzyme, collagenase, 
27 
 
 
in normal skin fibroblasts and granulation tissue fibroblasts (Buckley-Sturrock, 
Woodward et al. 1989, Tan, Rouda et al. 1993).   
1.6 Hypothesis and Objectives 
1.6.1 Rationale 
Biomaterial scaffold membranes hold great promise for use in GTR applications in that 
they can be fabricated to mimic the fibrous ECM architecture of the connective tissue and 
can be used to deliver growth factors, thus acting as a mechanically stable substitute 
ECM during tissue repair.  Electrospun PCL scaffolds loaded with bFGF microspheres 
have been shown to enhance dermal fibroblast infiltration in vitro and enhance 
angiogenesis in cutaneous wounds in vivo (Guo, Elliott et al. 2012).  Since dermal 
fibroblasts differ from gingival fibroblasts (Palaiologou, Yukna et al. 2001) and the 
periodontium represents a unique wound healing environment, it is of significance to 
study the response of gingival fibroblasts to bFGF loaded electrospun PCL scaffolds and 
subsequently assess the ability of the scaffolds to promote gingival wound healing.   
1.6.2 Overall Hypothesis 
We hypothesize that the sustained release of bFGF from PLGA microspheres loaded on 
an electrospun PCL scaffold with a pore diameter of 17.1 ± 8.3 µm will serve as a matrix 
for gingival fibroblast ingrowth and promote gingival wound healing.   
1.6.3 Specific Hypothesis and Objectives 
Release of bFGF from PCL electrospun scaffolds will increase the proliferation, matrix 
deposition and infiltration of gingival fibroblasts while maintaining a barrier to oral 
epithelial cells.  bFGF release from PCL electrospun scaffolds will accelerate gingival 
wound healing.  To test this hypothesis the following objectives were formulated: 
1. To characterize the influence of PCL electrospun fibrous scaffolds loaded with 
bFGF microspheres on human gingival fibroblasts in vitro and gingival tissue ex 
vivo. 
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a. Assess human gingival fibroblast attachment, proliferation and matrix 
synthesis and deposition. 
b. Assess cell infiltration from gingival tissue explants. 
2. To assess the influence of PCL electrospun fibrous scaffolds loaded with bFGF 
microspheres on the rate of wound healing following gingivectomy in a rat model. 
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Chapter 2 
2 Influence of Electrospun Polycaprolactone Fibrous 
Scaffolds Loaded with Basic Fibroblast Growth Factor 
Microspheres on Gingival Augmentation 
2.1 Introduction 
Periodontal disease affect the tissues that support the teeth (AAP 2001). Collectively 
referred to as the periodontium, these tissues are comprised of the alveolar bone, 
cementum, periodontal ligament (PDL) and the gingiva.  Periodontal disease ranges in 
severity from mild inflammation of the gingiva, termed gingivitis, to more aggressive 
bacterial-induced inflammatory conditions.  Periodontitis is the more severe periodontal 
pathology in which the chronic presence of bacteria induces a host immune response 
resulting in the loss of connective tissue attachment to the tooth; destruction of the 
gingiva, PDL, and cementum followed by resorption of the alveolar bone which can 
result in tooth mobility and loss (Pihlstrom, Michalowicz et al. 2005).  Periodontitis is 
one of the most common connective tissue disorders worldwide and affects 47% of the 
U.S. adult population (Eke, Dye et al. 2012). In addition to its high prevalence, the main 
concern with periodontitis is the limited capacity for repair of the periodontium, and 
without surgical intervention, the disease is irreversible (Bartold, McCulloch et al. 2000).   
Conventional interventions remove the causative bacterial agents and serve to slow the 
progression of periodontitis, but do not facilitate appreciable or predictable regeneration 
of the lost periodontal structures.  Such interventions often result in tissue shrinkage and 
fibrosis leaving the patient with gingival recession (Wikesjo and Selvi 1999, Hughes, 
Ghuman et al. 2010).  Guided tissue regeneration is a surgical intervention for 
periodontitis wherein a barrier membrane is placed under the gingival connective tissue 
and against the tooth to function as a space making barrier excluding the gingival tissue 
from the regenerating periodontal defect, thus creating a compartment into which the 
PDL and alveolar bone can repopulate (Aurer and Jorgic-Srdjak 2005).  Resorbable 
membranes for GTR have been developed as they eliminate the need for a second surgery 
for membrane removal.  However, the membranes employed are not optimal exhibiting 
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variable clinical improvement, therefore significant improvements can be made to their 
design (Bartold, McCulloch et al. 2000).  As current membranes are cell occlusive, 
gingival connective tissue is isolated from the periodontal pocket cutting off a potential 
supply of stem and progenitor cells from the healing defect along with the rich vascular 
supply (Schroeder and Listgarten 1997, Fournier, Larjava et al. 2013).   
With increasing knowledge of wound healing and advances in technology in the field of 
materials science, biomaterial scaffold-membranes can be fabricated which play a more 
active role in periodontal wound healing.  PCL is a bioresorbable, aliphatic polyester (Mw 
80 000) with a relatively long degradation time (Dong, Liau et al. 2009).  PCL is an ideal 
biomaterial for use in scaffold membrane applications due to its low cost, ease of 
fabrication, biocompatibility, and has been approved by the U.S. Food and Drug 
Administration for medical applications (Dong, Liau et al. 2009).  Several techniques 
exist for fabrication of fibrous biomaterial scaffolds including phase separation (Nam and 
Park 1999), self-assembly (Zhang 2003) and electrospinning (Pham, Sharma et al. 2006).  
Electrospinning is advantageous in that the set-up is convenient and cost effective, and 
unlike the other methods, is easily scalable (Dong, Liau et al. 2009).  Electrospinning 
produces scaffolds which are ideal for tissue regeneration applications due to the ability 
to customize fiber diameter and orientation, the high surface area to volume ratio, 
interconnected porosity, and the ability to incorporate growth factors, thus closely 
mimicking the structure of the natural ECM.  Moreover, by tailoring the pore size 
between the fibers in the scaffold, cell migration into and through the scaffold can be 
facilitated (Lowery, Datta et al. 2010).   
In addition to alterations in the structure of the scaffold, incorporation of growth factors 
into the scaffold increases their biocompatibility and functionality. The heparin-binding 
protein bFGF is a potent mitogen capable of stimulating fibroblast proliferation in a dose-
dependent manner (Gospodarowicz 1974, Nugent and Iozzo 2000).  bFGF is also a potent 
stimulator of angiogenesis in vivo and stimulates the migration and proliferation of 
endothelial cells in vitro (Gospodarowicz, Ferrara et al. 1987, Murakami and Simons 
2008).  bFGF accelerates the healing of oral wounds and stimulates periodontal 
regeneration in animal models (Murakami, Takayama et al. 1999, Murakami, Takayama 
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et al. 2003, Oda, Kagami et al. 2004, Ayvazyan, Morimoto et al. 2011).  These 
observations were further investigated in clinical trials that found that topical applications 
of bFGF were able to regenerate periodontal tissue in patients with periodontitis 
(Kitamura, Nakashima et al. 2008, Kitamura, Akamatsu et al. 2011).  While bFGF has 
shown promise clinically, topical application is not an optimal method of delivery due to 
the requirement for a large dose to be administrated in an effort to compensate for the 
rapid degradation and inactivation of growth factors delivered this way.  Attempts at 
sustained release of bFGF from scaffolds has been investigated using 
chitosan/hydroxyapatite freeze dried scaffolds and collagen/gelatin scaffolds (Tigli, 
Akman et al. 2009, Akman, Tigli et al. 2010).  However these scaffolds either have a 
fairly rapid release of bFGF or rapid degradation of the scaffold itself.  We have 
previously developed a PCL electrospun scaffold loaded with microspheres of poly 
(lactide-co-glycolide) containing a core of bFGF stabilized with heparin, which supported 
the migration of dermal fibroblasts into the scaffold in vitro and promoted angiogenesis 
following subcutaneous implantation (Guo, Elliott et al. 2012).  
The aim of this study was to investigate the in vitro biocompatibility of human gingival 
fibroblasts on PCL electrospun scaffolds loaded with bFGF microspheres and the 
efficacy of the scaffolds in the early stages of gingival wound healing in vivo.  The 
attachment, proliferation, infiltration/migration, and matrix synthesis of human gingival 
fibroblasts on scaffolds loaded with bFGF microspheres was evaluated and compared to 
scaffolds without bFGF.  We then assessed the influence of PCL scaffolds loaded with 
bFGF microspheres on reepithelialization and connective tissue formation following 
gingivectomy in a rat model.   
2.2 Materials and Methods 
2.2.1 Cell Cultures and Tissue Explants 
Human gingival fibroblasts (hGFs) were isolated and cultured from clinically healthy 
gingival tissue received from patients undergoing routine dental surgery at Western 
University Schulich School of Medicine and Dentistry Oral Surgery Clinic with informed 
patient consent.  hGFs were cultured from both male and female patients aged 15 to 79 
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years of age.   Excised gingival tissue was isolated in Dulbecco’s Modified Eagle 
Medium (DMEM) (Gibco, Cat # 11995-065, Carlsbad, CA, USA) supplemented with 
10% fetal bovine serum (FBS) (Gibco, Cat # 12483-020) and antibiotic-antimicotic (AA) 
(100 U/mL penicillin, 100 µg/mL streptomycin and 0.25 µg/mL amphotericin B; Gibco, 
Cat # 15240-062) at 4°C.  Tissue was rinsed in phosphate buffered saline (PBS), pH 7.4 
(Gibco, Cat # 10010-023) and the epithelium was mechanically separated from 
underlying connective tissue using a No. 15 scalpel blade.  Connective tissue was minced 
and cultured on polystyrene tissue culture treated plates (Corning, Tewksbury, MA, 
USA) in DMEM supplemented with 10% FBS and AA (culture medium) at 37°C in a 
humidified atmosphere of 95% air and 5% CO2.  Once wells became confluent, gingival 
fibroblasts were dissociated from the growth surface using 0.05% Trypsin-EDTA (Gibco, 
Cat # 25300-054) and passaged 1:3 in 75 cm2 polystyrene tissue culture treated flasks 
(Corning).  For use in cell experiments, hGFs were grown to 80-90% confluence, 
dissociated from the growth surface, and cell number was determined using a Multisizer 
3 Coulter Counter (Beckman Coulter, Mississauga, ON, Canada).  Cells were used 
between passages 2 and 8 and in some instances frozen in liquid nitrogen prior to use.  
Experiments were carried out in culture media supplemented with 50 µg/mL ascorbic 
acid (experimental media) at 37°C in a humidified atmosphere of 95% air and 5% CO2.   
Gingival tissue explants (GTEs) were used directly for certain experiments.  The tissue 
was cut on five faces, leaving the surface epithelium undisturbed, using a No. 15 scalpel 
blade into 2 mm3 blocks composed of connective tissue and attached epithelium as 
illustrated in Figure 2.1.  GTEs were used immediately for experiments.   
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Figure 2.1 – Gingival tissue explant as an ex vivo experimental system. 
Gingival tissue was cut into cubes along five faces, with the exception of the epithelial 
surface, into 2 mm3 blocks to be used for experiments. 
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2.2.2 Electrospun Fibrous Polycaprolactone Scaffolds Loaded with 
bFGF 
Scaffolds were fabricated in, and obtained from the laboratory of Dr. Jianjun Guan (The 
Ohio State University, Columbus, OH, USA).  Briefly, scaffolds were created using a 
two-stream electrospinning and electrospraying apparatus.  Scaffolds were created by 
electrospinning a positively charged solution of PCL onto a negatively charged rotating 
collecting mandrel to form a fibrous construct.  Simultaneously during fabrication, a 
second positively charged stream was used to electrospray microspheres with a core-shell 
structure consisting of a basic fibroblast growth factor core and a shell of poly (lactide-
co-glycolide).  The result was a fibrous construct composed of PCL fibers with uniform 
distribution of PLGA microspheres with a bFGF core throughout.  The bFGF solution 
had a concentration of 150 µg/mL and contained 0.05 wt  % heparin to protect the bFGF 
from denaturation.  The rate at which the bFGF solution was injected during the 
fabrication process was altered to produce scaffolds with different amounts of bFGF.  An 
injection rate of 0.1 mL/hour and 0.7 mL/hour both with constant 1 mL/hour injection 
rate of PLGA created scaffolds with low bFGF and high bFGF loading, respectively.  The 
constant injection rate of PLGA in low and high bFGF loaded scaffolds maintained a 
uniform density and distribution of the microspheres within the scaffold (Guo, Elliott et 
al. 2012).  As a control, a scaffold without bFGF loading was also tested.   
The scaffolds were characterized (Guo, Elliott et al. 2012) and found to have a sustained 
bFGF release over a 28 day period in PBS at 37°C.  Approximately 50 mg pieces of 
scaffold released 35 ng and 20 ng for the high bFGF and low bFGF loading, respectively, 
over the 28 day period.  The kinetics of bFGF release were found to occur in two stages 
with a relatively fast and nonlinear release in the first seven days (25 ng for the high 
bFGF scaffold, and 15 ng for the low bFGF scaffold) followed by the remainder being 
released relatively slower with a linear release profile in the days following.   
Prior to use in experiments, the scaffolds were cut into appropriate sizes and sterilized in 
70% ethanol for 20 minutes at room temperature (RT) and washed three times for 5 
minutes in sterile water followed by one wash in experimental media for in vitro 
experiments and an additional wash in sterile water for in vivo experiments.   
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2.2.3 Human Gingival Fibroblast Attachment 
Scaffolds were cut into 6 mm disks using a disposable biopsy punch (Integra Miltex, 
York, PA, USA) and sterilized.  Scaffolds were placed into 96 well plates (Corning) and 
hGFs were seeded onto the scaffold surface at a density of 3.5 x 104 cells/cm2.  Cells 
were cultured on the scaffolds for 1, 2, 4 or 24 hours at which time they were gently 
rinsed once with PBS to remove non-adherent cells and fixed using 4% 
paraformaldehyde (PFA) in PBS at RT for 10 minutes.  Cell seeded constructs were 
rinsed three times with PBS and dehydrated through a graded series of ethanol (50%, 
70% and 90%) followed by three changes of anhydrous ethanol for 10 minutes per step.  
To preserve cell morphology, cell seeded constructs were immersed in 
hexamethyldisilazane (HMDS) (Sigma-Aldrich, St. Louis, MO, USA) for 15 minutes,  air 
dried for 30 minutes and stored in a desiccator overnight.  Samples were coated with 5 
nm osmium metal using a Filgen OPC80T Osmium Plasma Coater (Filgen, Midori-ku, 
Nagoya, Japan) and visualized by scanning electron microscopy (SEM) using a Hitachi 
3400-N Variable Pressure Scanning Electron Microscope (Hitachi, Mississauga, ON, 
Canada) to acquire images using an acceleration voltage of 2.00 kV.  Photoshop 7.0 
software (Adobe Systems Incorporated, San Jose, CA, USA) was used to pseudocolour 
attached cells. 
2.2.4 Gingival Fibroblast Cell Number 
Scaffolds seeded with hGFs at a density of 7 x 103 cells/cm2 in 96-well plates were 
cultured for 1, 5 or 9 days with the addition of 50 µL experimental media every 2 days.  
Cell number on the scaffolds at each time point was determined using a CyQUANT® 
Cell Proliferation Assay kit (Molecular Probes, Carlsbad, CA, USA) (Jones, Gray et al. 
2001).  At each experimental time point the media was gently removed and scaffolds 
were rinsed in PBS to remove non-adherent cells and residual media.  Scaffolds were 
transferred to a 500 µL microcentrifuge tube (Port City Diagnostics, Wilmington, NC, 
USA) and stored at -80°C until the end of the experimental culture period.  Once all 
experimental time points were frozen, the assay was conducted according to 
manufacturer’s specifications.  Briefly, scaffolds were thawed and incubated with 250 µL 
CyQUANT® GR working solution for 5 minutes at RT with vigorous vortexing.  200 µL 
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of the incubated working solution was transferred to a 96-well microplate.  A standard 
curve was created from a 1 x 106 hGF cell pellet frozen at the beginning of the 
experiment.  Sample fluorescence was measured using a Safire2 microplate reader 
(Tecan, Männedorf, Switzerland) at an excitation wavelength of 480 nm and an emission 
wavelength of 520 nm.   
2.2.5 Ex-Vivo Explant Cultures 
Gingival tissue explant blocks were placed on sterilized 6 mm scaffold disks in 3.5 cm 
diameter polystyrene dishes (Corning), oriented such that the surface epithelium was not 
in contact with the scaffold surface, and cultured submerged in experimental media for 3 
weeks.  Half of the media was removed and replaced every two days for the duration of 
the experiment taking care not to disrupt explant tissue.  Explant tissue and scaffolds 
were fixed in 10% neutral buffered formalin (Sigma-Aldrich) at 4°C overnight.  Samples 
were prepared for SEM (as described above) and for frozen sections. 
Samples to be used for frozen sections were prepared for embedding by rinsing in PBS 
once for 15 minutes, 4% sucrose (Sigma-Aldrich) in PBS three times for 15 minutes and 
sinking in 30% sucrose in PBS at 4°C overnight.  The following day, samples were rinsed 
in 30% sucrose in water three times for 15 minutes and sunk in a 50:50 mixture of 30% 
sucrose in water and VWR Premium Frozen Section Compound (VWR International, 
Radnor, PA, USA) for 1 hour at RT.  For embedding, the samples were sunk in VWR 
Premium Frozen Section Compound and placed in an embedding mold such that sections 
along the face of the block cut along the length of the scaffold.  Samples were frozen in 
liquid nitrogen until almost completely frozen then left on dry ice for 20 minutes to 
complete freezing.  Samples were stored in sealed containers at -20°C for short term 
storage.   
Frozen blocks were sectioned at 10 µm using a Leica CM3050 S cryostat (Leica, 
Wetzlar, Germany).  Sections containing explanted tissue were mounted on Superfrost 
Plus slides (Fisher Scientific, Waltham, MA, USA), air dried at RT and stored at -20°C 
until ready to be stained. 
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Three sections per sample, at least 50 µm apart, were stained for vimentin to visualize the 
location of cells of mesenchymal origin.  Additional sections were stained for keratin 17 
to localize epithelial cells.  Sections were rehydrated in PBS for 30 minutes at RT.  
Endogenous peroxidase activity was quenched with 3% hydrogen peroxide (H2O2) in 
methanol for 5 minutes.  Non-specific antibody binding was blocked using 10% horse 
serum for 30 minutes at RT prior to application of the primary antibody against vimentin 
(clone EPR3776, Abcam, Cambridge, England, UK) at a 1:400 dilution or keratin 17 
(A2175, NeoBiolab, Cambridge, MA,USA) at a dilution of 1:100.  Sections were 
incubated with the primary antibody at 4°C overnight.  Sections were rinsed three times 
in PBS to remove unbound antibodies and sections were incubated for 30 minutes at RT 
with ImmPRESS HRP Anti-Rabbit Ig (Peroxidase) reagent (Vector Laboratories, 
Burlingame, CA, USA).  Unbound reagent was rinsed from the section using PBS and 3, 
3ʹ-diaminobenzidine (DAB) peroxidase substrate (Vector Laboratories) was used to 
develop the reagent according to manufacturer’s instructions.  Colour development was 
stopped by rinsing sections with water.  Negative control sections were made by omitting 
the primary antibody.  All sections were counterstained using Harris Modified 
Hematoxylin Solution (Sigma-Aldrich).  Stained sections were imaged using an Axio 
Imager M1 microscope (Zeiss, Oberkochen, Germany) and AxioImager software.   
ImageJ 1.48v software (National Institutes of Health, Bethesda, MD, USA) was used to 
calculate the distance of each vimentin-positive cell from the surface of the scaffold.   
2.2.6 Immunocytochemical Analysis 
Scaffolds seeded with hGFs at a density of 8.8 x 104 cells/cm2 in 96-well plates were 
cultured for 3 or 7 days with the addition of 50 µL experimental media every 2 days.  
Cells were fixed with 4% PFA in PBS for 10 minutes, rinsed three times with PBS and 
blocked with 1% bovine serum albumin (BSA) in PBS for 30 minutes.  Scaffolds were 
incubated with primary antibodies diluted 1:100 in 1% BSA in PBS against the 
extracellular matrix (ECM) proteins biglycan (ab54855, Abcam), decorin (ab54728, 
Abcam) and fibronectin (EP5, Santa Cruz Biotechnology, Dallas, TX, USA) at 4°C 
overnight.  Scaffolds were gently washed with PBS five times for 10 minutes each and 
blocked with 1% BSA in PBS for 5 minutes.  Scaffolds were then incubated, protected 
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from light, for 90 minutes at RT with Alexa Fluor 488 Goat Anti-Mouse IgG antibody 
(Molecular Probes) at a 1:200 dilution.  Following incubation, the scaffolds were washed 
five times for 10 minutes in PBS and mounted on glass coverslips using Vectashield 
Mounting Medium (Vector Laboratories) with 4ʹ, 6-diamidino-2-phenylindole (DAPI).  
Samples were imaged using an Axio Observer.Z1 fluorescence microscope (Zeiss).  
Axiovision Software Release 4.8.0.0 was used to capture images.  Negative control 
samples were prepared with the omission of the primary antibody and used to set the 
threshold for fluorescence detection (Appendix D, F, H).  Due to the thickness of the 
samples being imaged, z-stacks were acquired and extended depth of focus was 
employed using the Axiovision software.    
2.2.7 Human Gingival Fibroblast Extracellular Matrix Gene 
Expression 
Scaffolds seeded with hGFs at a density of 2 x 105 cells/cm2 in 96-well plates were 
cultured for 3 or 7 days with the addition of 50 µL experimental media every 2 days.  
Total RNA was isolated using TRIzol Reagent (Ambion, Carlsbad, CA, USA).  Isolated 
RNA was purified using a PureLink RNA Mini Kit (Ambion) according to the 
manufacturer’s directions.  Quantitative real-time reverse transcription polymerase chain 
reaction (RT-qPCR) was used to determine the gene expression level of biglycan (BGN, 
Hs00959141_g1) and fibronectin (FN1, Hs01549958_m1).  15 µL reactions containing: 
3-15 ng RNA; qScript XLT One-Step RT-qPCR ToughMIX master mix reagent (Quanta 
Biosciences, Gaithersburg, MD, USA); TaqMan Gene Expression Assay (Life 
Technologies, Carlsbad, CA) containing PCR primers for FN1, BGN or 18S and a FAM 
dye labelled TaqMan probe; and RNase free water. Thermal cycling conditions for 
amplification were 30 minutes at 48°C (reverse transcription), 10 minutes at 95°C 
(polymerase activation) followed by 40 cycles of each 15 seconds at 95°C and 1 minute 
at 60°C (melt and anneal/extend, respectively).  A dilution series was created from 
pooled RNA samples to test the efficiency of each target gene expression assay primer 
and probe set compared to the reference gene, 18S.  Gene expression levels of FN1 and 
BGN were normalized to the levels of endogenous 18S rRNA.  Data are presented as a 
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relative quantification of gene expression of samples relative to the PCL alone scaffold at 
day 3 using the 2-ΔΔCT method (Livak and Schmittgen 2001).   
2.2.8 Rat Gingivectomy Model 
Fifteen adult female Wistar rats aged 8 to 20 weeks weighing between 160 and 370 g 
were used in experiments (a generous gift from the lab of Dr. Stephen Sims, Western 
University, London, ON, Canada).  All animal procedures were approved by the 
University Council on Animal Care of Western University.  Gingivectomy was 
performed on the maxiallary palatal gingiva or mandibular buccal gingiva by one 
operator (Figure 2.2).  Animals were anesthetized by intraperitoneal injection of 
Ketamine-Xylazine (75 mg/kg Ketamine and 10 mg/kg Xylazine).  A small, round dental 
instrument was used to disrupt the junctional epithelium and a No. 15 scalpel blade was 
used to raise a full-thickness 900 µm wide gingival flap along the first, second and third 
molars.  The No. 15 scalpel blade was then used to excise the soft connective tissue flap 
and a small dental blade was used to thoroughly remove any remaining soft connective 
tissue on the tooth or bone.  To maintain hemostasis, cotton swabs were held over the 
wound with slight pressure.  Wounds received either PCL alone, low bFGF or high bFGF 
scaffolds or no scaffold (empty defect) as a control (n = 6 wounds receiving low bFGF 
and high bFGF scaffolds and n = 9 wounds receiving PCL alone scaffold or an empty 
defect).  Two sterilized scaffold strips 1 mm x 3 mm in size were placed into the 
experimental surgical wounds on top of one another to create a double layer and held in 
place with a small amount of Vetbond tissue adhesive (Figure 2.2).  A subset of animals 
(n =3) with empty defects and PCL alone scaffolds were euthanized by carbon dioxide 
inhalation immediately following surgery completion to serve as a day 0 baseline.  
Remaining animals received 0.5 mg/kg Buprenorphine by subcutaneous injection twice 
daily for 48 hours post-surgery as an analgesic.  Animals were maintained on a standard 
lab chow powdered food diet and were allowed food and water ad libitum for the 
duration of the experiment.   
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Figure 2.2 - Gingivectomy in a rat model and scaffold placement. 
Gingivectomy was performed in adult female Wistar rats.  Soft gingival tissue was 
removed and two layers of sterilized scaffolds were placed in the defect.  A) Macroscopic 
view of scaffold placement in the gingival wound.  White arrow – Molars, Black arrow – 
Scaffold placement. B) Uninjured gingival tissue.  B – Alveolar bone, G – Gingiva, D – 
Dentin, E – Enamel space.  Dashed red line demarcates approximate location of wound 
edge to be created following gingivectomy.  C) Immediately following gingivectomy in 
an empty defect.  Dashed red line indicates wound edge.  D) Immediately following 
gingivectomy in a PCL alone treated defect.  Dashed red line indicates wound edge.  
Black arrow indicates the scaffold. 
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Animals were euthanized 3 (n = 6) or 7 (n = 6) days post-gingivectomy by carbon 
dioxide inhalation.  Heads were fixed in 10% neutral buffered formalin (Sigma) 
overnight at 4°C.  Jaws were excised and tissues were subsequently decalcified at 4°C for 
48 hours in two changes of Cal-Ex Decalcifier (Fisher Chemical, Waltham, MA, USA).  
Molars were processed en bloc for frozen sections or by routine paraffin embedding.  
Serial 5 µm sections were taken in the mesio-distal plane encompassing the second 
molar.  
Sections were rehydrated and stained with hematoxylin (Sigma) and eosin (alcoholic; 
Leica) (H&E), Van Gieson, and Masson’s Trichrome.  Images were taken with a Leica 
DM100 light microscope (Leica).  Histomorphometric analysis of H&E stained sections 
of the wounds was completed using ImageJ 1.48v software (National Institutes of Health, 
USA) to measure the epithelial migration distance, the area of regenerated gingival 
connective tissue, and biologic width; as indicated by connective tissue attachment and 
junctional epithelium length (Khuller and Sharma 2009) (Figure 2.3).  Connective tissue 
attachment was measured from the crest of the alveolar bone to the apical most epithelial 
attachment.  Junctional epithelium length was measured from the most apical epithelial 
attachment to the bottom of the gingival sulcus.  Biologic width was the combined 
measurement of connective tissue attachment and junctional epithelium length (Figure 
2.3).   
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Figure 2.3 - Biologic width. 
Measurements of biologic width were made on H&E stained sections of rat gingival 
wounds.  Measurement parameters are indicated on uninjured tissue.  Horizontal green 
lines demarcate boundaries between which measurements are made, vertical lines 
indicate distances measured.  Biologic width (BW) is the combined measurement of 
connective tissue attachment (CTA) and junctional epithelium length (JE).  Sulcular 
depth (SD) is indicated, however does not contribute to the biologic width measurement.  
Red dashed line demarcates the approximate location of the wound edge which would be 
created following gingivectomy. 
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Immunohistochemical staining for arginase-1 (V-20:sc-18354, Santa Cruz), alpha smooth 
muscle actin (α-SMA) (clone 1A4, A5228, Sigma-Aldrich) and proliferating cell nuclear 
antigen (PCNA) (ab2426, Abcam) was performed to visualize M2 phenotype 
macrophages, myofibroblasts (α-SMA positive cells not associated with blood vessels) 
and proliferating cells in the wound area, respectively.  Sections were rehydrated, 
permeabilized using 0.1% Triton X-100 in PBS for 5 minutes at RT, rinsed in PBS and 
blocked using 10% horse serum.  Sections were incubated with primary antibodies 
against arginase-1, α-SMA and PCNA diluted 1:100 in 10% horse serum for 1 hour at 
room temperature.  Sections were rinsed in PBS and incubated, protected from light, for 1 
hour at RT with an appropriate Cy5 conjugated secondary antibody.  Sections were rinsed 
with PBS to remove unbound antibody and mounted using Vectashield Mounting 
Medium with DAPI.  Sections were imaged using an AxioImager.M2m (Zeiss) with Zen 
software (Zeiss).  Negative control sections were created in which the primary antibody 
was omitted and used to set the threshold level for fluorescence detection (Appendix L).  
ImageJ 1.48v software (National Institutes of Health, USA) was used to quantify the 
number of myofibroblasts and proliferating cells in the wound area.  
2.2.9 Statistical Analysis 
Data are presented as mean ± SD of triplicate experiments.  Statistical analysis was 
performed using GraphPad Prism software version 5.01 for Windows (GraphPad 
Software, San Diego, CA, USA).  Data were analyzed using a two-way ANOVA with 
Bonferroni’s post-test, with the exception of biologic width calculations which were 
analyzed using a one-way ANOVA with Kuskal-Wallis post-test. A p-value of less than 
0.05 was considered statistically significant.   
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2.3 Results 
2.3.1 Attachment and Morphology of hGFs on PCL Electrospun 
Scaffolds Loaded With bFGF 
SEM was used to visualize hGF attachment, spreading and morphological changes on 
scaffolds with and without bFGF loaded microspheres.  hGFs attached within 1 h and 
began spreading, with extension of cellular processes along the scaffold fibers evident on 
all scaffold types (Figure 2.4A).  Cells attached to and spanned across multiple fibers 
within the scaffolds, but remained on the surface of the scaffolds.  By 2 h both cell 
processes and cell bodies began penetrating the scaffolds, and were evident under the top 
fiber layer (Figure 2.4B).  Cell morphology was observed to be influenced by the 
underlying fiber architecture of the scaffolds.  By 24 h cells on scaffolds containing 
bFGF were seen to make contact with the microspheres (Figure 2.4B).  
2.3.2 bFGF Loaded PCL Electrospun Scaffolds Increase hGF Cell 
Number  
Increase in hGF cell number on each scaffold was assessed at 1, 5, or 9 days post-
seeding.  All three scaffolds supported an increase in cell number as DNA content on 
each of the three scaffolds increased with time (Figure 2.5).  At 5 days post-seeding, the 
low bFGF loaded scaffold significantly increased cell number compared to the PCL alone 
scaffold and the high bFGF loaded scaffold for one of the patient cells tested.  At 9 days 
post-seeding, the scaffold with low bFGF loading significantly increased cell number 
compared to the PCL alone scaffold for two of the patient cells tested while the hGFs 
from the third patient showed a significantly larger cell number on the scaffold with high 
bFGF loading (Figure 2.5).   
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Figure 2.4 - hGF attachment and morphology. 
A) SEM micrographs show hGFs (pseudo-coloured blue) attached to and spread along 
the scaffold fibers on PCL electrospun scaffolds both with and without bFGF 
microspheres at 1 hour.  The scaffold architecture influenced cell morphology.  Red 
arrows indicate cell contact with bFGF loaded microspheres.  Scale bar = 50 µm  B) 
Higher magnification SEM micrographs showing cells contacting the fibers of the 
scaffold with both large and small cell processes in as little as 1 hour.  By 2 hours, cell 
processes were seen extending down into the scaffold and cell bodies were seen below 
the superficial fibers.  Red arrows indicate cell contact with bFGF loaded microspheres.  
Scale bar = 30 µm (1 and 24 hours), Scale bar = 20 µm (2 and 4 hours).  Images are 
representative of a single experiment.   
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Figure 2.5 - hGF cell number. 
hGFs were seeded onto all three scaffold types and cultured for 1, 5 or 9 days.  Cell 
number at each time point was determined by quantification of DNA using a 
CyQUANT® assay.  Data are presented as mean ± SD of the fold change in cell number 
relative to the PCL alone scaffold at day 1.  Data are presented as individual donor 
patient cells with three experimental replicates.  Two-way ANOVA with Bonferroni’s 
post-test was conducted to compare means, *p<0.05, **p<0.01, ***p<0.001.   
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2.3.3 Interaction of Gingival Explant Tissue with PCL Electrospun 
Scaffolds Loaded with bFGF 
In the next experiments, gingival tissue explants were cultured on the surface of PCL 
electrospun scaffolds with and without bFGF microspheres for three weeks.  Cells grew 
out from the explants on all scaffold surfaces and appeared as cell sheets on the top of the 
scaffold fibers.  Sheets on the scaffolds containing bFGF appeared more confluent 
(Figure 2.6B, C), whereas on the PCL alone scaffold (Figure 2.6A) cells are more 
sparsely distributed on the scaffold surface.  
To further assess cell growth and migration on and into the scaffolds, sections of gingival 
tissue explants cultured on the scaffolds for three weeks were cut and cell type assessed 
using vimentin immunoreactivity, which allows separation of cells of mesenchymal 
origin and epithelial cells. Vimentin-positive cells had migrated into the scaffolds with 
and without bFGF from the explants (Figure 2.7A).  Scaffolds with high bFGF loading 
had significantly more cells than scaffolds with low bFGF loading or with no bFGF 
loading for at least one depth from the scaffold surface in all three patient tissues 
(p<0.05) (Figure 2.7B).  Two of the three patient tissues showed significantly more cells 
in the high bFGF scaffold as compared to the scaffold without bFGF for several depths 
from the scaffold surface (p<0.05) while the third patient tissue showed this trend, 
however it was not statistically significant (Figure 2.7B).   
In some instances the epithelium from the explanted gingival tissue migrated along the 
exterior surface of the tissue at the interface between the tissue and the scaffold.  The 
epithelial cell phenotype was assessed by non-reactivity to vimentin and positive labeling 
for keratin 17 (Figure 2.8).  In both instances, the epithelial cells showed minimal 
migration into the interior of the scaffold, staying on the surface of both the PCL alone 
and high bFGF loaded scaffold. The epithelial sheet on the high bFGF loaded scaffold 
qualitatively was thicker than the epithelial sheet migrating along the PCL alone scaffold.   
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Figure 2.6 - SEM of gingival tissue explants. 
Gingival tissue explants consisting of gingival connective tissue and attached epithelium 
were cultured on the surface of PCL electrospun scaffolds with and without bFGF 
loading for 3 weeks.  SEM micrographs show cells (pseudo-coloured blue) on the surface 
of the scaffold adjacent to the gingival tissue explants (pseudo-coloured purple).  A) PCL 
alone scaffold.  B) Low bFGF scaffold.  C) High bFGF scaffold.  Images are 
representative of a single experiment using tissue from one patient.  Scale bars = 500 µm. 
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Figure 2.7 - Population of the PCL electrospun scaffolds by cells from gingival tissue 
explants. 
A) Vimentin-positive cells were observed within the interior of the scaffolds both with 
and without bFGF.  Red dashed lines delineate the PCL scaffolds. Red arrows indicate 
vimentin-positive cells within the scaffolds. Images are representative of three patient 
tissues with three experimental replicates. Scale bars = 200 µm.  B) The distance each 
vimentin-positive cell was located from the surface of the scaffold was measured for 
three separate patient tissues.  Scaffolds with high bFGF loading had significantly more 
cells than scaffolds with no bFGF or low bFGF for at least one depth from the scaffold 
surface in all three patient tissues.  *p<0.05, **p<0.01, ***p<0.001.  Two-way ANOVA 
with Bonferroni post-test was conducted to compare means.  Data presented for each 
patient as mean ± SD of three sections from three experimental replicates.   
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Figure 2.8 - PCL electrospun scaffolds as a barrier to oral epithelial cells. 
When epithelial cells from the explant tissue migrated to the interface between the tissue 
and the scaffold, epithelial cells migrated along the surface of the scaffold with minimal 
penetration into the scaffolds.  Vimentin staining, excluding epithelial cells, and keratin 
17 staining, a marker of epithelial cells, showed minimal scaffold penetration by 
epithelial cells both in the presence and absence of bFGF microspheres.  Red dashed lines 
delineate the PCL scaffold.   
 
 
 
 
 
 
 
73 
 
 
 
 
  
74 
 
 
2.3.4 hGF ECM Secretion is Modulated by bFGF on PCL 
Electrospun Scaffolds 
We next investigated whether addition of bFGF to the scaffolds influenced secretion and 
deposition of fibronectin, biglycan, and decorin by hGF cells seeded onto the scaffolds.  
Localization of all three ECM proteins on the surface of each scaffold was initially 
visualized with fluorescent microscopy at low magnification (Appendix C, E, G) to 
qualitatively assess deposition across a large scaffold area.  Higher magnification images 
were taken to assess deposition on the surface of the scaffold associated with the cells.  
Fibronectin deposition was evident on all scaffold types after 3 days (Figure 2.9).  By 7 
days of culture, fibronectin deposition on the surface of the scaffold remained evident on 
all three of the scaffold types.   
Biglycan immunoreactivity was observed on the surface of the scaffolds after 3 days of 
culture although remained intracellular with little evidence of secretion into the ECM 
(Figure 2.10).  Biglycan appeared most prominent on the PCL alone scaffold and was 
diminished in the presence of bFGF release.  After 7 days of culture, biglycan 
immunoreactivity remained intracellular.   
At 3 days post-seeding, decorin immunoreactivity is observed on all of the scaffold types 
(Figure 2.11).  Decorin immunoreactivity appeared to be most prominent in the presence 
of bFGF and was mainly associated with the cells.  After 7 days of culture, decorin 
remained associated with the cells. 
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Figure 2.9 - Fibronectin immunoreactivity on the scaffold surface. 
The secretion and deposition of the structural ECM protein fibronectin by hGFs cultured 
on the scaffold was visualized on the scaffold surface using immunocytochemistry; 
fibronectin (green), nuclei (blue).  Fibronectin deposition is evident after 3 days on all 
three scaffold types.  After 7 days, fibronectin deposition remains evident on the surface 
of all three scaffold types.   Images are representative of three independent experiments. 
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Figure 2.10 - Biglycan immunoreactivity on the scaffold surface. 
The secretion and deposition of the small ECM proteoglycan biglycan by hGFs cultured 
on the scaffolds was visualized on the scaffold surface using immunocytochemistry; 
biglycan (green), nuclei (blue).  Biglycan immunoreactivity was observed intracellularly 
after 3 days on all three scaffold types. Biglycan appears most prominent on PCL alone 
scaffolds and appears to be diminished in the presence of increasing concentrations of 
bFGF.  After 7 days of culture, biglycan remains intracellular. 
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Figure 2.11 - Decorin immunoreactivity on the scaffold surface. 
The secretion and deposition of the small ECM proteoglycan decorin by hGFs cultured 
on the scaffolds was visualized on the surface of the scaffold using 
immunocytochemistry; decorin (green), nuclei (blue).  Decorin is observed on all three 
scaffold types at day 3 however appears most prominent in the presence of bFGF.  
Decorin remains associated with the cells after 7 days. 
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2.3.5 Effect of PCL Electrospun Fibrous Scaffolds Loaded with 
bFGF Microspheres on Fibronectin and Biglycan mRNA 
Relative mRNA levels of fibronectin (Figure 2.12A) and biglycan (Figure 2.12B) were 
assessed following culture on PCL electrospun scaffolds with and without bFGF 
microspheres for 3 or 7 days.  At both 3 and 7 days, neither fibronectin nor biglycan 
mRNA levels on scaffolds with low or high bFGF loaded microspheres was observed to 
be significantly different from that of the PCL alone scaffold (Figure 2.12A, B). 
2.3.6 Localization of M2 Macrophages in Rat Gingival Wounds 
Treated with PCL Electrospun Scaffolds 
The next set of experiments were conducted to assess the effect of each scaffold type on 
the rate of wound healing in a rat model following gingivectomy.  We first determined 
the effect of each scaffold type on inflammatory cells, in particular the M2 or 
alternatively activated macrophage phenotype, in healing rat gingival tissue following 
gingivectomy.  At 3 days, macrophages were observed primarily in the region of the 
developing granulation tissue in all treatments (Figure 2.13).  At 7 days, M2 macrophage 
populations appeared more prominent and were observed in the connective tissue around 
the crest of the alveolar bone in wounds treated with PCL alone and bFGF loaded 
scaffolds, whereas accumulation was predominantly located underneath the junctional 
epithelium at the junction of the epithelium with the tooth surface in untreated wounds.   
2.3.7 Proliferating Cells in Rat Gingival Wounds Treated with PCL 
Electrospun Scaffolds  
To determine the effect of the scaffolds on the proliferation of cells in healing rat gingival 
tissue, sections were stained for proliferating cell nuclear antigen (PCNA), a marker of 
active DNA replication (Figure 2.14A).  At 3 days post-wounding, proliferating cells 
were observed in the connective tissue at the wound edge for all treatments (Figure 
2.14B).  In addition, proliferating cells were observed in the basal epithelial cell layer in 
all treatments.  At 7 days post-wounding, proliferating cells are evident in the connective 
tissue and basal epithelial cells in all treatment groups (Figure 2.14B).    Proliferating 
cells were quantified and no significant differences were observed between treatments at 
3 or 7 days post-wounding (Figure 2.14C) 
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Figure 2.12 - Influence of PCL electrospun scaffolds loaded with bFGF on 
fibronectin and biglycan mRNA levels. 
hGFs were seeded and cultured on PCL electrospun fibrous scaffolds with and without 
bFGF microspheres for 3 or 7 days.  RNA was isolated and qRT-PCR was performed 
using primers specific for FN and BGN.  mRNA levels were normalized to endogenous 
18S ribosomal RNA levels.  A) Release of bFGF from the microspheres did not 
significantly alter the levels of fibronectin mRNA from that of the PCL alone scaffold at 
3 or 7 days.  B) Release of bFGF from the microspheres did not significantly alter the 
levels of biglycan mRNA from the PCL alone scaffold at either 3 or 7 days.  Graphs 
represent mean ± SD of three independent experiments conducted with different patient 
cells, with three replicates per experiment.  Effect of treatments were analyzed via a two-
way ANOVA with a Bonferroni post-test to compare differences between means, p<0.05.   
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Figure 2.13 - M2 macrophage localization following in vivo gingivectomy. 
Gingivectomy was performed in rats, and wounds were treated with scaffold membranes 
of PCL alone, low bFGF loaded, high bFGF loaded or no treatment (empty defect).  
Localization of arginase 1 (cyan), a marker of M2 macrophages, was visualized with 
immunohistochemistry using a Cy5 conjugated secondary antibody with Hoechst dye 
counterstaining (blue) to visualize nuclei in the tissue and imaged with fluorescent 
microscopy.   Images are representative of three individual experiments.  A) Arginase 1 is 
observed in the granulation tissue at 3 days and in the connective tissue of the gingiva at 
7 days.   In wounds treated with scaffolds, M2 macrophage populations are localized 
around the crest of the alveolar bone. T – Tooth, B – Alveolar bone.  B) Higher 
magnification images of the areas in A) indicated by white boxes.  M2 macrophages 
become more abundant at 7 days and in wounds treated with all three scaffold types, M2 
macrophages are localized around the crest of the alveolar bone, whereas in the empty 
defect they are localized under the junctional epithelium.   
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Figure 2.14 - Cell proliferation following in vivo gingivectomy. 
Gingivectomy was performed in rats, and defects were treated with scaffold membranes 
of PCL alone, low bFGF loaded, high bFGF loaded or no treatment (empty defect).  
Sections were labelled with a primary antibody for PCNA and visualized with an 
appropriate Cy5 conjugated secondary antibody (red) with Hoechst dye counterstain 
(blue) to visualize nuclei in the tissue.  Images are representative of three independent 
experiments.  A) Proliferating cells were observed in the connective tissue and basal 
epithelial layer for all treatments at both 3 and 7 days post-wounding. T – Tooth, B – 
Alveolar bone.  Scale bar = 500 µm.  B) Higher magnification images of the areas in A) 
indicated by white boxes.  Proliferating cells are evident in the connective tissue and 
basal epithelial cell layer at both 3 and 7 days for all treatments.  C) The number of 
PCNA positive cells in the wound was quantified at 3 and 7 days post-wounding and 
plotted as mean ± SD of three independent experiments.  Two-way ANOVA with a 
Bonferroni post-test was used to compare means.  No significant difference in the number 
of PCNA positive cells in the healing wounds were observed between treatments at either 
3 or 7 days. 
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2.3.8 Myofibroblasts in Rat Gingival Wounds Treated with PCL 
Electrospun Scaffolds  
Myofibroblasts in healing rat gingival tissue were visualized by immunostaining for α-
SMA and identified as α-SMA positive fibroblasts in the connective tissue not in the 
vasculature (Figure 2.15A, B, Appendix K).  Myofibroblasts were observed in the wound 
area at 3 days for all treatments and became more abundant at 7 days for all treatments 
(Figure 2.15C). 
2.3.9 Collagen Deposition in Rat Gingival Wounds Treated with 
PCL Electrospun Scaffolds 
To visualize the deposition of collagen in healing rat gingival tissue following 
gingivectomy, sections were stained with Van Gieson’s stain (Figure 2.16A, B) and 
Masson’s trichrome (Figure 2.16C, D).  In addition, collagen was visualized in uninjured 
tissue and immediately following gingivectomy (Appendix J).  At day 3, the original 
wound margin is visible using both stains as indicated by the termination of the pre-
existing thick collagen fibers in the connective tissue.   At 7 days, dense collagen 
accumulation is noted in the newly formed connective tissue of untreated wounds and 
wounds treated with scaffolds containing bFGF.  Black arrows indicate areas of dense 
collagen accumulation.  In the high bFGF treated wound collagen fibers are seen to 
extend into the free gingiva.   
2.3.10 Connective Tissue Area in Rat Gingival Wounds Treated 
with PCL Electrospun Scaffolds 
Gingival wounds were assessed at 3 and 7 days post-wounding to quantify the amount of 
newly formed connective tissue in the wound area (Figure 2.17A).  3 days post-wounding 
granulation tissue was observed in the wound area for all scaffold treatments and the 
empty defect (Figure 2.17B).   At 7 days, the general architecture of the gingival 
connective tissue appeared to be restored in all treatment groups (Figure 2.17A). 
Connective tissue area was quantified and no difference was observed between treatment 
groups (Figure 2.17B).   
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Figure 2.15 - Myofibroblast populations following in vivo gingivectomy. 
Gingivectomy was performed in rats, and defects were treated with scaffold membranes 
of PCL alone, low bFGF loaded, high bFGF loaded or no treatment (empty defect).  A) 
Sections were labelled with a primary antibody for α-SMA and visualized with an 
appropriate Cy5 conjugated secondary antibody (red) with Hoechst dye counterstain 
(blue) to visualize nuclei in the tissue.  T – Tooth, B – Alveolar bone.  Scale bar = 500 
µm.  B) Higher magnification images of the areas in A) indicated by white boxes.  The 
number of α-SMA positive myofibroblasts not associated with vasculature in the wound 
area were quantified at 3 and 7 days post-wounding and plotted as mean ± SD of three 
independent experiments.  Two-way ANOVA with Bonferroni’s post-test was used to 
compare means.  No significant difference in the number of myofibroblasts in the healing 
wounds were observed between treatments at either 3 or 7 days.   
 
93 
 
 
 
94 
 
 
  
95 
 
 
 
 
 
 
 
 
 
  
96 
 
 
 
 
 
 
 
 
 
Figure 2.16 - Collagen deposition following in vivo gingivectomy. 
Gingivectomy was performed in rats, and defects were treated with scaffold membranes 
of PCL alone, low bFGF loaded, high bFGF loaded or no treatment (empty defect).  A) 
Collagen was visualized at 3 and 7 days post-gingivectomy using Van Gieson’s staining 
(pink).  B) Higher magnification images of the areas indicated in A) by the black boxes. 
C) Masson’s trichrome staining was used to visualize collagen (blue) in the healing rat 
gingival wounds.  D) Higher magnification images of the areas indicated in C) by the 
black boxes.  Images are representative of three independent experiments. Scale bars = 
200 µm.  At day 3 for all treatments, the boundary of the created wounds is visible as 
indicated by the termination of the pre-existing dense collagen fibers in the gingival 
connective tissue, labelled with black arrows [B), D)].  7 days post-wounding, areas of 
dense collagen fibers in the newly formed tissues of the untreated and bFGF scaffold 
treated wounds were visible, as indicated by black arrows [B), D)].   
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Figure 2.17 - Connective tissue area following in vivo gingivectomy. 
Gingivectomy was performed in rats, and defects were treated with scaffold membranes 
of PCL alone, low bFGF loaded, high bFGF loaded or no treatment (empty defect).  A) 
Area of newly formed tissue in the gingival connective tissue was quantified from H&E 
stained histological sections at 3 and 7 days post-wounding.  Solid green line indicates 
the quantified area of newly formed tissue.  Scale bar = 500 µm.  B) Newly formed tissue 
area was quantified and plotted as mean ± SD of three individual experiments.  Newly 
formed tissue was observed in the wound area at day 3 for all treatments with increased 
tissue area observed at day 7.  Two-way ANOVA with Bonferroni’s post-test was used to 
compare means.  No significant difference in regenerated connective tissue area was seen 
between treatments.   
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2.3.11 Epithelial Migration in Rat Gingival Wounds Treated with 
PCL Electrospun Scaffolds 
The distance the epithelium had migrated from the original wound location was measured 
in the healing rat gingival tissue from H&E stained sections (Figure 2.18A).  At 3 days 
post-gingivectomy, the epithelium was observed to have migrated towards the tooth from 
the location of the original wound in all treatment groups (Figure 2.18B).  Epithelial 
migration increased with time and was greater at 7 days than at 3 days for all treatments.  
At day 7 the epithelium in all treatment groups was observed to contact the tooth (Figure 
2.18A). 
2.3.12 Biologic Width of Rat Gingival Wounds Treated with PCL 
Electrospun Scaffolds 
Histomorphometric analysis of H&E stained rat gingival wound sections was conducted 
to determine the biologic width of the healing tissue at 7 days, as at 3 days none of the 
wounds were reepithelialized (Figure 2.19A).  Connective tissue attachment was 
measured from the crest of the alveolar bone to the most coronal attachment of 
connective tissue to the tooth.  No statistically significant difference in connective tissue 
attachments between treatments was observed (Figure 2.19B).   
Junctional epithelium length was measured as the second component of the biologic 
width of the gingiva.  A junctional epithelium was present for all treatments (Figure 
2.19A).  No statistically significant difference in the length of the junctional epithelium 
was observed between treatments (Figure 2.19C).   
The biologic width of the gingiva was calculated by the addition of the connective tissue 
attachment to the junctional epithelium length.  Biologic width between treatments was 
not significantly different at day 7 and all groups were observed to have a biological 
width similar to that of healthy, uninjured gingival tissue (Figure 2.19D).   
 
  
104 
 
 
 
 
 
 
 
 
Figure 2.18 - Epithelium length following in vivo gingivectomy. 
Gingivectomy was performed in rats, and defects were treated with scaffold membranes 
of PCL alone, low bFGF loaded, high bFGF loaded or no treatment (empty defect).  A) 
The length of the epithelium was measured from the original wound from H&E stained 
histological sections at 3 and 7 days post-wounding.  Solid green line indicates distance 
migrated.  Scale bar = 500 µm.  B) Migration distance was measured and plotted as mean 
± SD of three individual experiments.  The epithelium migrated from the original wound 
towards the tooth at day 3 with epithelial migration distance increasing at day 7 for all 
treatments.  Two-way ANOVA with Bonferroni’s post-test was used to compare means.  
No significant difference in epithelial migration distance was seen between treatments at 
3 or 7 days.   
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Figure 2.19 - Biologic width measurement following in vivo gingivectomy. 
Following gingivectomy in rats, defects were treated with scaffold membranes of PCL 
alone, low bFGF loaded, high bFGF loaded or no treatment (empty defect).  A) Biologic 
width measurements were made from H&E stained histological sections at 7 days post-
wounding as at 3 days the wounds were not reepithelialized.  Horizontal solid green lines 
indicate demarcations between measured components as outlined in the methods.  
Measured distances are indicated by vertical solid green lines on each section.  Scale bar 
= 500 µm.  B) Connective tissue attachment was measured and plotted as mean ± SD of 
three individual experiments.  One-way ANOVA with Kruskal-Wallis post-test was used 
to compare means.  Connective tissue attachment was observed at 7 days for all 
treatments with no significant difference between treatments.  C) Junctional epithelium 
length was measured and plotted as mean ± SD of three individual experiments. One-way 
ANOVA with Kruskal-Wallis post-test was used to compare means.  At day 7 a 
junctional epithelium was present for all treatments with no significant difference in 
length between treatments.  D) Biological width was calculated as the sum of connective 
tissue attachment and junctional epithelium length and plotted as mean ± SD of three 
independent experiments. One-way ANOVA with Kruskal-Wallis post-test was used to 
compare means.  No significant difference in biological width was observed between 
treatments. 
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2.4 Discussion 
GTR employs a cell occlusive barrier membrane to prevent the oral epithelium migrating 
along the tooth root into periodontal defects, precluding connective tissue attachment to 
the tooth (Karring, Nyman et al. 2000, Polimeni, Xiropaidis et al. 2006). The use of an 
occlusive barrier membrane for GTR is not optimal as it physically separates the 
periodontal defect from the gingival connective tissue, the latter representing a rich 
source of vascular beds (Bartold, Walsh et al. 2000) and potentially cell populations such 
as pericytes and mesenchymal progenitor cells which could contribute significantly to 
periodontal healing (Fournier, Larjava et al. 2013).  Therefore the development of 
membranes that would allow gingival connective tissue integration, while maintaining a 
barrier to the oral epithelium, would be extremely advantageous.  In this study, using 
hGFs, human gingival explants and in vivo rat models, we investigated the efficacy of a 
porous electrospun fibrous PCL scaffold with microspheres containing bFGF as a 
potential new material for periodontal GTR applications.  
We utilized polycaprolactone (PCL) as the base polymer for the modified barrier 
membrane for several key reasons.  Firstly, it is FDA-approved, which allows for faster 
clinical translation, and it is already used as a root-end filling material in endodontics (de 
Souza Filho, Gallina et al. 2012).  Secondly, as we have done, it can readily be 
electrospun into fibers to produce a scaffold rather than an impermeable membrane.  In 
addition, although it is not biodegradable in physiological systems, it is bioresorbable 
through hydrolysis of its ester linkages, which typically occurs over a 12-month period 
(Woodruff and Hutmacher 2010).  As periodontal tissues are slow to regenerate, 
hydrolysis over a 12-month period is advantageous.  
To assess the efficacy of the scaffold, we first investigated the in vitro response of hGFs 
to the scaffolds.  SEM revealed that hGFs attached to the fibers of all scaffold types 
within 1 hour following seeding on the scaffold surface.  The observation of broad cell 
extensions and cell spreading indicates strong attachment to the scaffold fibers as non-
adherent fibroblasts display a more rounded morphology (Rosen and Culp 1977).  Both 
cell alignment and orientation are strongly influenced by the underlying topography, in 
this case, multiple fibers under each cell (Brunette, Kenner et al. 1983, Brunette 1986, 
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Hamilton, Oakley et al. 2009).  Cellular orientation in response to aligned electrospun 
fibers has been noted for several different cell types and scaffold materials (Baker and 
Mauck 2007, Murugan and Ramakrishna 2007, Nisbet, Forsythe et al. 2009, Shang, Yang 
et al. 2010).  Fiber diameter is a significant factor influencing fibroblast alignment with 
the greatest degree of alignment observed along fibers of 10 µm diameter (Hwang, Park 
et al. 2009).  The PCL electrospun scaffolds used in this study had a fiber diameter of 7.4 
± 2.0 µm (Guo, Elliott et al. 2012) and although smaller than 10 µm, still influence hGF 
morphology.  The significance of cell alignment is considerable, as it is known to alter 
downstream cellular processes including proliferation and differentiation, and matrix 
deposition (Chou, Firth et al. 1995, Glass-Brudzinski, Perizzolo et al. 2002).  
In gingival wound healing, fibroblasts proliferate and migrate into the wound site. PCL 
electrospun scaffolds with and without bFGF support an increase in hGF population 
growth in vitro as indicated by an increase in cell number on all three scaffold types 
tested, in a temporal manner.  bFGF is a potent mitogen of fibroblast cells 
(Gospodarowicz 1974) and the addition of bFGF microspheres to the scaffold 
significantly increases the cell number of hGFs cultured on the scaffold.  This suggests 
that the addition of bFGF microspheres to PCL electrospun scaffolds enhances the 
scaffold bioactivity.  Variability in the degree of cell number increase was observed 
between patients, which could be attributed to donor patient age (Bartold, Boyd et al. 
1986, Caceres, Oyarzun et al. 2014).  Future studies will focus on an increased analysis 
of cells isolated from patients of different ages.  As gingival recession and periodontal 
disease predominantly affect more elderly populations, it will be important to quantify if 
bFGF release would be effective in the induction of proliferation in cells from patients in 
this age range.  
As they enter the wound site, hGFs contribute to granulation tissue formation and 
synthesize ECM components to replace the provisional matrix (Aukhil 2000, Hakkinen, 
Uitto et al. 2000).  Fibronectin is the first component of granulation tissue secreted by 
fibroblasts (Hakkinen, Uitto et al. 2000) and is found in the gingival tissue in health 
(Connor, Aubin et al. 1984, Steffensen, Duong et al. 1992).  hGFs cultured on all three 
scaffold types were observed to secrete fibronectin onto the scaffold surface after 3 days 
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and 7 days of culture on the scaffold.  Fibronectin deposition was organized 
predominantly in the direction of the cell long axis.  It has been previously demonstrated 
that fibronectin deposition can be altered by variations in substratum topography, such 
that our observations are not unexpected (den Braber, de Ruijter et al. 1998).  Fibronectin 
mRNA transcript levels were not significantly altered by the release of bFGF from the 
microspheres on the PCL electrospun scaffolds, which was unexpected as bFGF has been 
shown to increase fibronectin expression in a dose-dependent manner (Xie, Bian et al. 
2008).   
Decorin, a small leucine-rich proteoglycan, is a major component of gingival connective 
tissue where it associates with type I collagen fiber bundles (Hakkinen, Oksala et al. 
1993).  Decorin is secreted by fibroblasts in culture where it associates with fibronectin 
(Schmidt, Robenek et al. 1987).  Decorin production by hGFs cultured on PCL 
electrospun scaffolds was visible at 3 days and was most notable on the scaffold 
containing high bFGF microspheres.  Following 7 days of culture, decorin production 
appeared localized to the cells, suggesting cells are not actively secreting the 
proteoglycan.  This is consistent with previous findings that bFGF upregulates decorin 
gene expression in dermal fibroblasts (Tan, Hoffren et al. 1993).  Finally, we assessed 
deposition of biglycan, a small leucine-rich proteoglycan that makes up a minor 
component of human gingival connective tissue where it associates with type I collagen 
fiber bundles in the deep connective tissue (Hakkinen, Oksala et al. 1993, Alimohamad, 
Habijanac et al. 2005).  Biglycan production by hGFs on PCL electrospun scaffolds was 
evident after 3 and 7 days and appeared to be attenuated in a bFGF dose-dependent 
manner.  Biglycan gene expression of hGFs cultured on the electrospun PCL scaffolds 
was not significantly altered by the release of bFGF from the microspheres. Interestingly, 
previous studies have shown that bFGF downregulates biglycan gene expression in 
dermal fibroblasts in vitro, suggesting that gingival fibroblasts may differ in response to 
bFGF (Tan, Hoffren et al. 1993).  Overall, our data demonstrates that PCL scaffolds with 
or without bFGF support matrix fibrillogenesis, which will be an important determinant 
of regeneration of the connective tissue.  
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Ex-vivo gingival explant cultures more closely mimic the in situ environment, as cells 
would be required to migrate through the collagenous ECM of the tissue to enter the 
scaffold. Therefore, we next investigated whether cells would migrate from explants onto 
the scaffold and whether this was influenced by the presence of bFGF.  SEM analysis 
demonstrated that cell outgrowth from gingival tissue explants was evident on the surface 
of all scaffold types.  In tissue sections, bFGF release significantly promoted scaffold 
infiltration by mesenchymal cells (vimentin+ cells) compared to PCL alone scaffolds, 
with increased cell number correlated with higher bFGF concentrations.  We chose bFGF 
primarily because it is a potent chemotactic agent for fibroblast cells (Buckley-Sturrock, 
Woodward et al. 1989) and based on the increased cell number seen within the scaffolds 
containing both low and high bFGF, it appears to function when released from the 
microspheres.  However, bFGF is also a potent mitogen for fibroblast cells 
(Gospodarowicz 1974) and cell proliferation within the scaffold cannot be eliminated as a 
contributing factor to the increase in cell population in the presence of bFGF 
microspheres.  To investigate the individual contribution of migration and proliferation to 
scaffold population in future studies, proliferation of cells within the explant tissue will 
be inhibited using mitomycin C (Tomasz 1995).  However, as we hypothesized, 
mesenchymal cells from the gingival connective tissue are able to infiltrate the scaffolds 
through the pores.  
Oral epithelial cells are known to migrate quickly in vivo (Hamilton, Chehroudi et al. 
2007).  As highlighted previously, conventional GTR membranes are cell-occlusive and 
are designed to block this aggressive migration into the pocket (Needleman, Worthington 
et al. 2006).  While the scaffolds supported the infiltration of mesenchymal cells, they 
excluded the infiltration of oral epithelial cells. Oral epithelial cells found at the interface 
between the scaffold and the explant tissue were observed to migrate along the surface of 
the scaffold as a sheet with minimal infiltration below the surface of the scaffold.  We 
attribute this to the pore size of the scaffolds (17.1 ± 8.3 µm with pore size ranging from 
6.8 – 47.2 µm (Guo, Elliott et al. 2012)).   The function of epithelial cells in vivo is to 
form coverings and linings over tissues.  In vitro epithelial cells tend not to migrate into 
pitted topographies and rather form coverings over pits with dimensions of 45 µm2 
openings (Hamilton, Chehroudi et al. 2007).  bFGF stimulates the proliferation of 
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gingival epithelial cells in a dose-dependent manner, however the stimulation is 
somewhat attenuated in the presence of serum (Takayama, Yoshida et al. 2002).  In the 
current study, epithelial cells did not penetrate scaffolds even in the presence of bFGF 
release from the microspheres, however on high bFGF loaded scaffolds the epithelial 
layer appeared larger, likely in a state of hyperproliferation.  Both topical and sustained 
release of bFGF in palatal wound healing in vivo has been shown to accelerate wound 
epithelialization and increase the proliferation of basal epithelial cells (Oda, Kagami et al. 
2004, Ayvazyan, Morimoto et al. 2011).  The morphology of the healing epithelial layer 
following topical application of bFGF was found to be morphologically similar to that of 
the control wounds (Oda, Kagami et al. 2004), however bFGF administration using a 
sustained method increased the epithelial ridges observed as compared to the control 
(Ayvazyan, Morimoto et al. 2011).  The sustained release of bFGF from the microspheres 
in the PCL electrospun scaffolds used in this study may account for the observed 
differences in epithelial sheet thickness from the tissue explants. Of particular 
significance is the observation that the PCL electrospun scaffold excludes oral epithelial 
cells.  This result has significant implications for membrane design as it demonstrates that 
it is not necessary for GTR membranes to be completely cell-occlusive to prevent the 
migration of the oral epithelium.  As has been previously demonstrated, the strict 
occlusion of the gingival connective tissue from a regenerating periodontal defect is not a 
critical requirement for the successful regeneration of periodontal structures (Wikesjo, 
Lim et al. 2003); however, occlusion of the oral epithelium is (Linghorne and O'Connell 
1950).  Our scaffolds accomplish this as indicated by the infiltration of and population by 
cells of mesenchymal origin while simultaneously maintaining a barrier to oral epithelial 
cells.   
Based on their efficacy in vitro, we next assessed each scaffold type in a rat gingivectomy 
model, with healing responses at 3 and 7 days investigated.  The initial stage of wound 
healing is characterized by an inflammatory response and inflammatory responses are 
commonly elicited following the implantation of biomaterials (Polimeni, Xiropaidis et al. 
2006, Garg, Pullen et al. 2013).  The regenerative, alternatively activated M2 phenotype 
macrophages are typically associated with tissue repair and the polarization of 
macrophages to the M2 phenotype is influenced by scaffold architecture, therefore we 
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investigated the M2 macrophage response following treatment with PCL electrospun 
scaffolds (Fairweather and Cihakova 2009, Garg, Pullen et al. 2013).   In all wounds, M2 
macrophage populations were prominent in the connective tissue at 7 days post-
wounding and were localized under the junctional epithelium in untreated wounds. 
However, in scaffold treated wounds, M2 macrophage populations were observed around 
the crest of the alveolar bone, although the presence of bFGF appeared to have no effect 
on macrophage persistence.  Although bFGF is not proinflammatory, studies have shown 
that under inflammatory conditions in dermal tissues bFGF potentiates the recruitment of 
inflammatory cells (Zittermann and Issekutz 2006).  However, our results are consistent 
with the observation that the addition of bFGF to a collagen scaffold implanted in rat 
palatal submucoperiosteal tissue did not alter the inflammatory response.  The scaffolds 
used in this study had a mean pore diameter of 17.1 ± 8.3 µm with pore size ranging from 
6.8 – 42.7 µm (Guo, Elliott et al. 2012) which has been shown in other studies to be 
favourable for M2 macrophage polarization in the early inflammatory response (Garg, 
Pullen et al. 2013).  In addition, scaffolds with aligned fibers minimized host response 
compared to randomly oriented fibers (Cao, McHugh et al. 2010).   
We next assessed whether the presence of bFGF within the scaffolds influenced cell 
proliferation.  In the healing gingival tissue, proliferating cells were observed in the 
epithelium and connective tissue for all treatments at both 3 and 7 days post-wounding.  
The presence of bFGF at both low and high loading did not significantly alter the number 
of proliferating cells at either 3 or 7 day post-wounding compared to both the empty 
defect and the PCL alone scaffold.  Since bFGF is a potent mitogen and exhibits 
stimulatory effects on gingival epithelial cell proliferation, increased cell proliferation in 
healing rat gingival wounds treated with PCL electrospun scaffolds containing bFGF 
would be expected (Gospodarowicz 1974, Takayama, Yoshida et al. 2002).  The 
mitogenic effects of bFGF have been demonstrated following topical application to oral 
mucosa wounds wherein an increase in the number of proliferating basal epithelial cells 
was noted and at higher concentrations  proliferation of cells within the connective tissue 
was evident (Oda, Kagami et al. 2004).  Myofibroblasts, characterized by α-SMA 
expression, are transiently present during wound healing and contribute to matrix 
production and contraction, however persistence of myofibroblasts is associated with scar 
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formation and fibrosis (Shi, Lin et al. 2013).  bFGF treatment downregulates α-SMA 
gene expression and induces apoptosis of both dermal and oral mucosal myofibroblasts 
(Funato, Moriyama et al. 1997, Funato, Moriyama et al. 1999, Shi, Lin et al. 2013).  In 
the current study, myofibroblasts in the healing rat gingiva treated with PCL electrospun 
scaffolds were observed at 3 days and became more abundant at 7 days.  The presence of 
bFGF on the scaffolds did not significantly alter the number of myofibroblasts observed 
in the healing rat gingival wounds.  This is unexpected as bFGF induces the apoptosis of 
myofibroblasts and studies have shown that the addition of bFGF to collagen scaffolds 
implanted in the submucosal tissue of the rat palate reduce the number of myofibroblasts 
observed within and around the scaffold at 7 and 14 days following implantation (Funato, 
Moriyama et al. 1997, Funato, Moriyama et al. 1999, Jansen, van Kuppevelt et al. 2009).  
It is possible that the scaffolds used in this study may show an effect at a later time point, 
such as 14 days post-wounding, as myofibroblast differentiation in a healing wound 
generally occurs around day 6 and populations accumulate until day 15 where 
myofibroblasts comprise 70% of granulation tissue fibroblasts (Darby, Skalli et al. 1990, 
Hakkinen, Uitto et al. 2000).   
During granulation tissue formation, fibroblasts initially secrete fibronectin which is 
gradually replaced with a fibrillar type I collagen matrix (Kurkinen, Vaheri et al. 1980, 
Hakkinen, Uitto et al. 2000).  In the present study, we investigated the collagen 
deposition in rat gingival wounds using histochemical staining.  At 7 days post 
wounding, dense collagen accumulation is observed in the connective tissue of untreated 
wounds and wounds treated with scaffolds containing bFGF.  Studies of healing rat 
palatal wounds found that treatment with topical bFGF application resulted in the 
formation of mature collagen fibers in the granulation tissue adjacent to the pre-existing 
fibers at 7 days post-wounding whereas mature collagen fibers were absent in untreated 
control wounds suggesting that bFGF may accelerate the maturation of collagen (Oda, 
Kagami et al. 2004).  Studies looking at longer time points of 6 weeks found that 
following mucoperiosteal denudation of the rat palate, collagen accumulation was 
decreased in the submucosa of the gingiva in wounds receiving a topical application of 
bFGF (Choi, Kawanabe et al. 2008).  In this study, collagen deposition was evident in the 
gingival connective tissue at 7 days and future studies using longer time points would be 
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of interest to investigate collagen deposition in response to scaffold membrane treatment 
following tissue remodeling.   
Treatment with the scaffold membranes did not have a significant effect on the area of 
granulation tissue formed at 3 days, the area of connective tissue regenerated at 7 days or 
the length of the neoformed epithelium at 3 or 7 days.  This is unexpected as studies have 
shown topical bFGF applications to rat palatal wounds increases the rate of granular 
tissue formation and reepithelialization of these wounds (Oda, Kagami et al. 2004).  
However, the concentration used for topical application was greater (0.5 and 3.0 µg) than 
that of the scaffold used (~25 ng cumulative release over 7 days from a 50 mg piece of 
high bFGF loaded scaffold (Guo, Elliott et al. 2012)).  In this study, treatment with PCL 
scaffold membranes did not significantly affect the biologic width of the reepithelialized 
wound at day 7.  Taken together, these results suggest that the scaffolds are 
biocompatible for use as a GTR membrane. 
bFGF exerts its effects in a dose-dependent manner (Gospodarowicz 1974, Takayama, 
Murakami et al. 2001, Ayvazyan, Morimoto et al. 2011, Ma, Wang et al. 2012) therefore 
this study looked at two loading doses of bFGF on the PCL scaffolds.  In vitro, high 
bFGF loading appeared to be more effective for population of the scaffolds by 
mesenchymal cells from gingival tissue explants as compared to the low bFGF loading 
dose, whereas experiments in which a finite cell number was seeded onto the scaffolds, 
the low bFGF loading dose promoted a greater increase in cell number.  bFGF loading 
dose did not significantly alter the mRNA expression levels of fibronectin or biglycan.  
When tested in vivo the two loading doses of bFGF were not significantly different for 
any of the parameters tested: proliferating cell number, myofibroblast number, connective 
tissue area, neoformed epithelium length or biologic width.  These results suggest that the 
loading dose of bFGF in the microspheres of PCL scaffold membranes for use in 
periodontal regeneration could be optimized to determine the concentration which 
promotes accelerated would healing in vivo.  In addition, for translation to clinical 
studies, dosing would need to be further optimized.   bFGF in the microspheres was 
stabilized by heparin (Nissen, Shankar et al. 1999) and retains its biological activity 
following release from the microspheres (Guo, Elliott et al. 2012), however over time the 
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age of the scaffold may have contributed to a loss of bioactivity of the bFGF in the 
microspheres.   
2.5 Conclusion 
In conclusion, we have shown that PCL electrospun fibrous scaffolds are biocompatible 
when tested in vitro with hGFs as evidenced by cellular attachment, increase in cell 
number with time and matrix deposition, and when tested with gingival tissue explants ex 
vivo as indicated by population of the fibrous construct by mesenchymal cells.  The 
release of bFGF from microspheres contained within the PCL scaffolds promotes the 
population of the scaffolds by mesenchymal cells from gingival tissue explants and 
increases hGF cell number on the scaffolds.  Importantly, the scaffolds were found to act 
as a barrier to oral epithelial cells in vitro, as indicated by minimal epithelial cell 
penetration into the scaffold interior.  In vivo all three scaffold types were found to be 
biocompatible in a rat model of gingival repair.  These results suggest that with further 
optimization for in vivo testing, PCL electrospun scaffolds show promise as a bioactive, 
porous GTR membrane alternative.   
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Chapter 3 
3 General Discussion 
3.1 Summary and Conclusions 
Objective #1: To characterize the influence of PCL electrospun fibrous scaffolds 
loaded with bFGF microspheres on human gingival fibroblasts in vitro and 
gingival tissue ex vivo 
a. Assess human gingival fibroblast attachment, proliferation and matrix 
synthesis and deposition on PCL electrospun scaffolds loaded with 
bFGF 
In this study, hGFs were found to attach and spread on all three scaffold types 
with cell morphology being influenced by the fibers of the scaffold.  All three 
scaffolds supported an increase in hGF cell number temporally with bFGF 
loading promoting an increase in cell number. Qualitative assessment of ECM 
deposition on the surface of the scaffolds using immunocytochemistry revealed 
that hGFs secreted a fibronectin matrix onto the scaffolds both with and without 
bFGF loading, whereas biglycan and decorin remained mainly intracellular on all 
scaffolds.  bFGF did not alter the deposition of fibronectin appreciably, however 
appeared to reduce biglycan immunoreactivity and increase decorin 
immunoreactivity.  Neither bFGF concentration significantly altered fibronectin 
or biglycan mRNA levels.  
b. Assess cell infiltration from gingival tissue explants into PCL 
electrospun scaffolds loaded with bFGF 
In this set of experiments, cells of mesenchymal origin, vimentin+, were found to 
populate the PCL electrospun scaffolds with cell density increasing in a bFGF 
dose-dependent manner.  Oral epithelial cells from the explant tissue were found 
to remain on the surface of the scaffold with little penetration into the scaffold 
interior observed on both PCL alone and high bFGF loaded scaffolds.   
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Taken together, these results suggest that the PCL electrospun scaffolds loaded 
with bFGF are able to act as an epithelial cell-occlusive membrane while 
facilitating interaction with hGFs and mesenchymal cells. 
Objective #2: Assess the influence of PCL electrospun fibrous scaffolds loaded 
with bFGF microspheres on the rate of wound healing following gingivectomy in 
a rat model 
In a rat gingivectomy model, treatment with PCL electrospun scaffolds localized 
populations of alternatively activated M2 phenotype macrophages around the 
crest of the alveolar bone.  Scaffolds both with and without bFGF loading did not 
significantly change the number of proliferating cells or myofibroblasts in the 
healing wound.  Collagen deposition was observed in the regenerating gingival 
connective tissue at day 7 in wounds treated with scaffolds loaded with bFGF.  
The area of newly formed connective tissue, epithelial length and biologic width 
did not show any significant difference in wounds treated with any scaffold type.  
The results of this study suggest that PCL scaffolds both with and without bFGF 
loading are biocompatible in a model of gingival healing. 
3.2 Contributions to the Current State of Knowledge 
3.2.1 General Significance 
Periodontal diseases are highly prevalent in the Western population and require surgical 
intervention to halt disease progression and induce regeneration of the lost tissues.  GTR 
procedures are currently used as a surgical method to regenerate the periodontium, but 
the membranes currently employed are cell-occlusive and when used clinically, results 
have been variable and unpredictable (Chen and Jin 2010).  Functionally excluding the 
gingival connective tissue from the regenerating defect is suboptimal as it excludes the 
rich vascular plexus, pericytes and progenitor cells of the gingival connective tissue 
which could aid in the regeneration of the damaged periodontium (Schroeder and 
Listgarten 1997, Fournier, Larjava et al. 2013).  Exclusion of the oral epithelium from the 
regenerating periodontal defect is a requirement for the formation of a new connective 
tissue attachment to the tooth root (Polimeni, Xiropaidis et al. 2006), but exclusion of the 
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collagenous gingival connective tissue itself arises only from the need to block oral 
epithelial migration (Wikesjo, Lim et al. 2003).   Therefore the focus of this work was the 
development of a fibrous and bioresorbable scaffold as an alternative to cell-occlusive 
barrier membranes to allow recruitment of mesenchymal cells from the gingival 
connective tissue while maintaining a barrier to oral epithelial cells.  We demonstrate that 
PCL electrospun scaffolds allow the infiltration of mesenchymal cells while 
simultaneously posing a barrier to oral epithelial cell infiltration, with the addition of 
bFGF promoting mesenchymal cell population and an increase in hGF cell number on the 
scaffolds.  In vivo, the scaffolds were biocompatible in terms of the polarization of 
macrophages to a healing M2 phenotype, collagen deposition, connective tissue 
regeneration and biological width restoration.   
3.2.2 Role of Scaffold Architecture in Determining Cellular 
Responses 
It has been established that cells cultured on three dimensional substrates show numerous 
behavioral alterations including changes in adhesion, cytoskeletal organization, 
proliferation, morphology, and differentiation compared to cells in two dimensional 
culture (Friedl and Brocker 2000, Hakkinen, Harunaga et al. 2011, Rampichova, Chvojka 
et al. 2013).  Furthermore, the physical properties of the scaffolds themselves, such as 
fiber diameter, fiber orientation, and porosity play a significant role in the regulation of 
cellular morphology, proliferation, alignment, and migration of cells (Liu, Ji et al. 2009, 
Shang, Yang et al. 2010).  Fibroblast cells show preferential orientation along fibers of 10 
µm diameter (Hwang, Park et al. 2009) with hGFs showing alignment along the 7.4 ± 2.0 
µm fibers under investigation in this thesis.  Porosity of the scaffold is another feature 
which has significant effects upon cell behavior.  Optimal porosity allows for exchange 
of nutrients and wastes within the three dimensional scaffold facilitating development of 
a microenvironment for cellular growth (Rampichova, Chvojka et al. 2013).  For optimal 
cell proliferation, a pore size of between 6 -20 µm has been established for fibroblast 
cells.  As shown in this thesis, hGF cell number increases with time on the PCL 
electrospun scaffolds (pore size 17.1 ± 8.3 µm, pore size range of 6.8 – 42.7 µm).  
Porosity also dictates the level of matrix production by cells.  Larger pore sizes result in 
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cells attaching to single fibers slowing ECM production as opposed to cells spanning 
across multiple fibers (Lowery, Datta et al. 2010).  As demonstrated in this thesis, hGFs 
attach to and span across multiple scaffold fibers and secrete a fibronectin matrix.  
Porosity strongly influences cell migration into the interior of the scaffold, with small 
pore sizes excluding cells (Lowery, Datta et al. 2010).  The PCL electrospun scaffolds 
under study in this thesis allow for infiltration of mesenchymal cells into the scaffold 
interior and, of particular significance in terms of GTR membrane design, the scaffolds 
were observed to exclude oral epithelial cells.  As we have previously demonstrated, oral 
epithelial cells do not migrate into topographies of 45 µm2 (Hamilton, Chehroudi et al. 
2007).  Thus in vitro testing suggests that the porous, fibrous nature of the PCL 
electrospun scaffold shows improvement over current cell-occlusive GTR membranes in 
that it allows for attachment, cell number increase, and matrix deposition of hGFs and 
infiltration of mesenchymal cells while maintaining a barrier to oral epithelial cells.   
3.2.3 Role of bFGF in Scaffold Bioactivity 
bFGF is a potent mitogen of mesoderm derived cells and a potent chemotactic agent for 
fibroblasts (Gospodarowicz 1974, Buckley-Sturrock, Woodward et al. 1989).  Topical 
application of bFGF has been shown to accelerate oral wound healing (Fujisawa, 
Miyamoto et al. 2003, Oda, Kagami et al. 2004), however this method of application in 
periodontal defects is problematic as high concentrations of the growth factor are 
required to overcome the short half-lives resulting from enzymatic degradation and quick 
metabolization following application (Sun, Qu et al. 2012).  Suitable carriers are needed 
for the temporally sustained release of growth factors at a defect site.  In this thesis bFGF 
was stabilized with heparin and encapsulated in PLGA microspheres which were 
electrosprayed throughout the thickness of the fibrous PCL scaffold.  This method of 
growth factor delivery allows for a slow and temporally sustained release of the growth 
factor as the PLGA shell degrades (Guo, Elliott et al. 2012).  bFGF release from the 
microspheres increased the bioactivity of the scaffolds when tested in vitro as indicated 
by increased hGF number on scaffolds containing bFGF and increased mesenchymal cell 
density from gingival tissue explants.  Comparison of the two loading doses of bFGF 
suggest that the high loading dose of bFGF was more effective for scaffold population by 
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mesenchymal cells from ex vivo gingival tissue explants, whereas the low loading dose 
promoted the greatest increase of hGF cell number on the scaffolds.  In addition, high 
bFGF loading was found to dramatically upregulate versican mRNA expression levels at 
14 days of culture in previous experiments.  Taken together, these results suggest that 
bFGF release from the scaffolds increased their bioactivity when tested in vitro.   
3.2.4 PCL Electrospun Scaffolds Loaded with bFGF for Tissue 
Repair 
As the PCL electrospun scaffolds proved to be oral epithelial cell occlusive and allowed 
for infiltration of mesenchymal tissue in vitro they were subsequently tested for their 
ability to promote gingival tissue regeneration.  The gingiva is a critical component of the 
periodontium that functions to protect the underlying structures of the periodontium from 
the multitudes of bacterial species present in the oral environment (Schroeder and 
Listgarten 1997).  This is accomplished through the junctional epithelium of the gingiva 
forming a functional seal around the teeth along with adequate connective tissue 
attachment to the roots of the teeth.  If the gingiva becomes compromised, due to the 
repeated inflammatory insult associated with periodontitis, regeneration of the lost 
functional structure requires therapeutic intervention, such as GTR (Karring, Nyman et 
al. 2000) .  GTR procedures are based upon the concept of cell occlusion, specifically the 
oral epithelium, from a regenerating periodontal defect to allow for the reformation of 
connective tissue attachment to the tooth root (Karring, Nyman et al. 2000).  This is 
accomplished using occlusive membranes which also exclude the gingival connective 
tissue eliminating the rich vascular plexus and associated progenitor cells of the 
connective tissue from contributing to periodontal regeneration (Schroeder and Listgarten 
1997, Wikesjo, Lim et al. 2003, Fournier, Larjava et al. 2013).  In this thesis we have 
demonstrated that PCL electrospun fibrous scaffolds are biocompatible when used as an 
alternative GTR membrane in terms of macrophage polarization to a reparative M2 
phenotype, collagen deposition, connective tissue area regenerated, and connective tissue 
attachment, however the role of bFGF release from the scaffolds on the healing process 
remains to be fully quantified. 
129 
 
 
In addition to their use in periodontal regeneration, the scaffolds may also serve to 
facilitate dermal wound healing.  bFGF accelerates and plays a role in the reduction of 
scar formation, which is a common clinical problem associated with dermal wound 
healing (Akita, Akino et al. 2008, Shi, Lin et al. 2013).  Sustained release of bFGF from 
the scaffold may regulate the apoptosis of myofibroblasts and regulate ECM deposition 
thus lessening scar formation (Shi, Lin et al. 2013).  In addition, the scaffolds may be 
useful at promoting wound healing in diabetic patients, both in dermal and oral mucosal 
tissues, as topical bFGF application is shown to be effective at promoting wound healing 
in chronic diabetic wounds (Tan, Xiao et al. 2008).  One of the complications of diabetes 
is deficiencies in wound healing characterized by impairment of the inflammatory 
response, granulation tissue formation and angiogenesis (Desta, Li et al. 2010).  
Fibroblasts show increased apoptosis in diabetic gingival wounds which is postulated to 
play a role in the impaired wound healing response (Desta, Li et al. 2010).  Since bFGF is 
a potent mitogen for fibroblast cells, sustained release of bFGF from the scaffolds in a 
diabetic wound may serve to increase fibroblast proliferation thus rescuing granulation 
tissue formation.  The porous, fibrous architecture of the scaffold would serve as a 
support for cells infiltrating from the granulation tissue until the cells secrete their own 
matrix.   
3.3 Future Directions 
3.3.1 Adhesion Dynamics of Cellular Interaction with PCL 
Electrospun Scaffolds 
Cells attach to and interact with the extracellular matrix through adhesion sites.  These 
adhesion sites serve as transmembrane linkages between the extracellular matrix and the 
cytoskeleton (Burridge, Molony et al. 1987).  Adhesion is mediated through integrins 
which function as cell signaling molecules and can affect a diverse range of cell functions 
such as migration, proliferation, differentiation, and cell polarity (Streuli 1999, Friedl and 
Brocker 2000, Berrier and Yamada 2007).  Of particular importance is the response of 
cells to three dimensional substrates (Friedl, Zanker et al. 1998, Friedl and Brocker 
2000), such as the PCL electrospun scaffolds under investigation in this thesis.  To 
investigate the adhesion dynamics of hGFs on the PCL electrospun scaffolds, both with 
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and without bFGF, indirect immunofluorescence will be used to localize adhesion 
structures such as focal adhesion and focal complexes (vinculin, phosphorylated FAK, 
phosphorylated paxillin) and fibrillar adhesions (tensin, integrin α5β1) (Berrier and 
Yamada 2007) at 3 hours, 6 hours and 7 days post-seeding.  Due to the three dimensional 
structure of the scaffolds, confocal microscopy will be used to visualize labelled adhesion 
molecules thus giving information about the composition, localization, and size of the 
adhesions within the cell.  To further assess adhesion dynamics on the scaffolds, antibody 
inhibition assays will be conducted.  hGFs will be incubated with monoclonal antibodies 
to integrins α5β1 (three dimensional adhesions) and αvβ3 (two dimensional adhesions) 
prior to seeding on all three scaffold types.  Cells will be allowed to attach to the 
scaffolds for 2 and 24 hours to assess early and late attachment, respectively.  At each 
time point non adherent cells will be gently removed by rinsing and cell number on the 
scaffold will be assessed using an assay to quantify DNA content, such as the 
CyQUANT® assay, and compared to cells incubated with vehicle alone prior to seeding.    
Adhesion dynamics allow cells to interact with the underlying substratum and ECM, 
which in turn dictates ECM production (Mann, Tsai et al. 1999, Lowery, Datta et al. 
2010).  Characterization of the adhesion dynamics of hGFs on the scaffolds will allow for 
determination of the optimal fiber diameter of the scaffolds in order to promote matrix 
formation. 
3.3.2 Effect of Lipopolysaccharide on hGF Interaction with PCL 
Electrospun Scaffolds 
Wound healing and periodontal regeneration takes place under exposure to several 
bacterial species as the oral environment is home to several hundreds of distinct 
microbial species and is one of the most densely populated areas of the body by bacteria 
(Takahashi 2005).  Bacteria and their products can have a significant impact on wound 
healing and cellular response, and thus should be considered when modelling gingival 
wound healing in vitro.  Porphyromonas gingivalis (P. gingivalis) has been implicated in 
the etiology of periodontitis (Moore and Moore 1994) and lipopolysaccharide (LPS), a 
bacterial cell wall component, has been postulated to be a likely candidate for activation 
of the host inflammatory response (Kocgozlu, Elkaim et al. 2009).   Oral epithelial cells 
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and gingival fibroblasts produce inflammatory cytokines in response to P. gingivalis LPS 
stimulation (Wang and Ohura 2002, Kocgozlu, Elkaim et al. 2009).  Fibroblasts show 
dose dependent responses to Actinobacillus actinomycetemcomitans (A. 
actinomycetemcomitans) LPS with high concentrations inhibiting DNA synthesis 
whereas a slight stimulation of DNA synthesis was observed when exposed to low 
concentrations (Hill and Ebersole 1996).  Furthermore, A. actinomycetemcomitans LPS 
stimulation at high concentrations attenuated cell proliferation in response to bFGF 
whereas stimulation with low concentrations of A. actinomycetemcomitans LPS enhanced 
cell proliferation in response to bFGF (Hill and Ebersole 1996).   The LPS of P. 
gingivalis differs structurally from that of other Gram-negative bacteria (Wang and 
Ohura 2002), thus future experiments to assess the effects of LPS on hGFs cultured on 
the PCL electrospun scaffolds will be undertaken using P. gingivalis LPS and A. 
actinomycetemcomitans LPS, at both low (< 9 µg) and high concentrations (≥ 9 µg).  Cell 
number on PCL electrospun scaffolds with and without bFGF loading will be assessed in 
the presence of both species of LPS at both concentrations using a CyQUANT® assay to 
assess DNA content.  These experiments will allow us to gain insight into the potential 
effectiveness of the scaffolds under more physiologically relevant and challenging 
conditions which are present during periodontal regeneration.   
3.3.3 Analysis of PCL Electrospun Scaffolds on Initial and Late 
Wound Healing Response 
In this thesis we have analyzed the initial gingival wound healing response of rats treated 
with PCL electrospun scaffolds both with and without bFGF loading using histological 
sections for morphometric analysis and assessing collagen deposition and 
immunohistochemistry to analyze proliferating cell number, M2 macrophage polarization 
and myofibroblast number.  To further analyze the influence of the scaffolds on the 
biomolecular events occurring during gingival wound healing, scaffolds would be placed 
in the wounds and at 3 and 7 days post-wounding, gingival tissue would be harvested and 
mRNA isolated to look for changes in mRNA expression levels of ECM proteins such as 
collagen, fibronectin, tenascin-C, biglycan, deocrin and versican.  In addition, α-SMA 
mRNA expression levels could be analyzed to assess myofibroblast presence in the 
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healing wound.  The protein level of the previously listed ECM molecules and α-SMA 
could be analyzed using Western blots following protein isolation from the tissues.   
To characterize the late wound healing response, longer time-points will be used, such as 
2, 4 and 6 weeks.  During wound healing, myofibroblast differentiation occurs between 6 
and 15 days post-wounding with maximal myofibroblast population density observed at 
15 days (Darby, Skalli et al. 1990).  Since bFGF has been shown to induce the apoptosis 
of myofibroblasts (Funato, Moriyama et al. 1997, Funato, Moriyama et al. 1999, Kanda, 
Funato et al. 2003) it will be of interest to analyze the effects of the PCL electrospun 
scaffolds loaded with bFGF on myofibroblast population in the healing rat gingival 
wounds at the later time points of 14 and 28 days which could be accomplished using 
immunohistochemistry for localization of myofibroblasts in the healing wound, or with 
qRT-PCR and Western blots to examine the mRNA and protein expression level of α-
SMA, respectively.  Although occurring to a lesser extent than in dermal tissue, gingival 
tissue following healing may exhibit a denser than normal collagen-rich extracellular 
matrix which is particularly problematic if the maxilla is not fully developed (Choi, 
Kawanabe et al. 2008).  Since bFGF has been implicated in reducing collagen 
accumulation during oral wound healing (Choi, Kawanabe et al. 2008), investigation of 
collagen deposition at later time points would allow for assessment of the effect of the 
PCL electrospun scaffolds with and without bFGF on the deposition and remodeling of 
collagen in the healing rat gingiva.  This will be accomplished using tissue sections 
stained with Masson’s trichrome, Van Gieson’s stain and picrosirius red to allow for 
qualitative assessment of collagen deposition.  Collagen content in the healing tissues 
will be assessed using a hydroxyproline assay on healing tissue homogenates.  As 
hydroxyproline is almost exclusively found in collagen, this assay will give a quantitative 
measure of the collagen content of the tissue (Reddy and Enwemeka 1996). 
3.3.4 Assessing Cell Recruitment During Healing – Lineage 
Tracing to Assess the Role of Pericytes 
During wound healing, extracellular matrix is deposited and the wound is contracted 
through the actions of myofibroblasts (Hinz and Gabbiani 2010).  Interest in determining 
the source of myofibroblast populations in the healing wound have led to studies 
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implicating pericytes as a progenitor cell to the myofibroblast (Greenhalgh, Iredale et al. 
2013).  Pericytes are periendothelial cells found encircling the endothelial cells of the 
microvasculature (Greenhalgh, Iredale et al. 2013).  Lineage tracing experiments have 
identified cells in the perivascular space which are induced upon injury and are pro-
fibrotic (Dulauroy, Di Carlo et al. 2012).  Since myofibroblasts contribute to wound 
healing and are responsible for scar formation and fibrosis which contributes to gingival 
recession, it is of interest to analyze their recruitment during gingival regeneration and in 
response to scaffold treatment.  This will be accomplished using forkhead transcription 
factor FoxD1-Cre knock-in mice to allow for lineage tracing of pericytes.  In this model, 
a fusion protein of Cre recombinase and GFP will be expressed under the control of the 
FoxD1 locus (Humphreys, Lin et al. 2010).  Gingivectomy will be performed in these 
mice and PCL electrospun scaffolds with and without bFGF loading will be placed in the 
defect.  At time points of 3, 7, 14 and 28 days, wounds will be assessed using histological 
sections to localize and quantify differentiated pericytes in the stroma of the regenerating 
gingival tissue.  This will allow for determination of the role of pericytes in contributing 
to myofibroblast populations in gingival tissue and the role of bFGF on these populations.   
3.4 Limitations 
As with any scientific study, there are several limitations to this work.  Working with a 
three dimensional scaffold material poses challenges for reliable quantification of certain 
parameters.  One such consideration is the quantification of cell number from a three 
dimensional culture (Ng, Leong et al. 2005).  This was accounted for and the CyQUANT 
assay was used to give a measure of DNA content on the scaffolds, thus giving the most 
accurate measure of cell number.  Another concern is the need for a homogenous cell 
suspension from which the quantifications are made, which was taken into consideration 
and vigorous vortexing was employed to account for cells within the scaffold interior.  In 
this study we used immunofluorescence as a qualitative measure of assessing ECM 
deposition on the surface of the scaffolds, and although Western blot analysis could give 
a quantitative assessment of ECM secretion, this technique may be impractical for use 
with the three dimensional scaffolds.  Although decorin and biglycan are small (36 kDa 
and 38 kDa, respectively) (Fisher, Termine et al. 1989, Hering, Kollar et al. 1996), 
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fibronectin is secreted as a dimer composed of two monomers of molecular weight 220-
250 kDa (Potts and Campbell 1994).  The large molecular weight of fibronectin may 
impede its removal from the fibrous scaffold making it difficult to obtain complete 
protein removal from the scaffolds to ensure accurate quantification.   
The studies completed herein assumed that the bFGF released from the microspheres was 
at a sufficient concentration for in vivo experiments based on results from our in vitro and 
ex-vivo studies.  However in vivo, the effects were non-significant which could be due to 
a sub-optimal concentration of bFGF. Although our laboratory has previously 
demonstrated that the scaffolds stimulate angiogenesis in a mouse subcutaneous model, 
in vivo fibrogenic response was not investigated (Guo, Elliott et al. 2012). Further studies 
using scaffolds loaded with a wider range of bFGF concentrations could confirm this.  
3.5 Final Summary 
The results presented in this thesis demonstrate that PCL electrospun scaffolds loaded 
with bFGF support the attachment, matrix deposition and proliferation of hGFs with 
bFGF increasing cell number in a temporal manner.  The scaffolds are selectively cell 
permeable in that they support the infiltration of mesenchymal cells from gingival tissue 
while simultaneously excluding the infiltration of oral epithelial cells.  The scaffolds 
exhibit biocompatibility in the early stages of gingival wound healing in the rat.  This 
research suggests that PCL electrospun scaffolds, with or without bFGF microspheres, 
represent an alternative to the current cell-occlusive membranes used for GTR. 
 
 
 
 
135 
 
 
3.6 References 
Akita, S., K. Akino, T. Imaizumi and A. Hirano (2008). "Basic fibroblast growth factor 
accelerates and improves second-degree burn wound healing." Wound Repair Regen 
16(5): 635-641. 
Berrier, A. L. and K. M. Yamada (2007). "Cell-matrix adhesion." J Cell Physiol 213(3): 
565-573. 
Buckley-Sturrock, A., S. C. Woodward, R. M. Senior, G. L. Griffin, M. Klagsbrun and J. 
M. Davidson (1989). "Differential stimulation of collagenase and chemotactic activity in 
fibroblasts derived from rat wound repair tissue and human skin by growth factors." J 
Cell Physiol 138: 70-78. 
Burridge, K., L. Molony and T. Kelly (1987). "Adhesion plaques: sites of transmembrane 
interaction between the extracellular matrix and the actin cytoskeleton." J Cell Sci Suppl 
8: 211-219. 
Chen, F.-A. and Y. Jin (2010). "Periodontal Tissue Engineering and Regeneration: 
Current Approaches and Expanding Opportunities." Tissue Eng Part B Rev 16(2): 219-
255. 
Choi, W., H. Kawanabe, Y. Sawa, K. Taniguchi and H. Ishikawa (2008). "Effects of 
bFGF on suppression of collagen type I accumulation and scar tissue formation during 
wound healing after mucoperiosteal denudation of rat palate." Acta Odontol Scand 66(1): 
31-37. 
Darby, I., O. Skalli and G. Gabbiani (1990). "Alpha-smooth muscle actin is transiently 
expressed by myofibroblasts during experimental wound healing." Lab Invest 63(1): 21-
29. 
Desta, T., J. Li, T. Chino and D. T. Graves (2010). "Altered fibroblast proliferation and 
apoptosis in diabetic gingival wounds." J Dent Res 89(6): 609-614. 
Dulauroy, S., S. E. Di Carlo, F. Langa, G. Eberl and L. Peduto (2012). "Lineage tracing 
and genetic ablation of ADAM12(+) perivascular cells identify a major source of 
profibrotic cells during acute tissue injury." Nat Med 18(8): 1262-1270. 
Fisher, L. W., J. D. Termine and M. F. Young (1989). "Deduced protein sequence of 
bone small proteoglycan I (biglycan) shows homology with proteoglycan II (decorin) and 
several nonconnective tissue proteins in a variety of species." J Biol Chem 264(8): 4571-
4576. 
Fournier, B. P., H. Larjava and L. Hakkinen (2013). "Gingiva as a source of stem cells 
with therapeutic potential." Stem Cells Dev 22(24): 3157-3177. 
Friedl, P. and E.-B. Brocker (2000). "The biology of cell locomotion within three-
dimensional extracellular matrix." Cell Mol Life Sci 57: 41-64. 
136 
 
 
Friedl, P., K. S. Zanker and E.-B. Brocker (1998). "Cell migration strategies in 3-D 
extracellular matrix: differences in morphology, cell matrix interactions, and integrin 
function." Microsc Res Tech 43: 369-378. 
Fujisawa, K., Y. Miyamoto and M. Nagayama (2003). "Basic fibroblast growth factor 
and epidermal growth factor reverse impaired ulcer healing of the rabbit oral mucosa." J 
Oral Pathol Med 32: 358-366. 
Funato, N., K. Moriyama, Y. Baba and T. Kuroda (1999). "Evidence for apoptosis 
induction in myofibroblasts during palatal mucoperiosteal repair." J Dent Res 78(9): 
1511-1517. 
Funato, N., K. Moriyama, H. Shimokawa and T. Kuroda (1997). "Basic fibroblast growth 
factor induces apoptosis in myofibroblastic cells isolated from rat palatal mucosa." 
Biochem Biophys Res Commun 240: 21-26. 
Gospodarowicz, D. (1974). "Localisation of a fibroblast growth factor and its effect alone 
and with hydrocortisone on 3T3 cell growth." Nature 249: 123-127. 
Greenhalgh, S. N., J. P. Iredale and N. C. Henderson (2013). "Origins of fibrosis: 
pericytes take centre stage." F1000Prime Rep 5: 37. 
Guo, X., C. G. Elliott, Z. Li, Y. Xu, D. W. Hamilton and J. Guan (2012). "Creating 3D 
angiogenic growth factor gradients in fibrous constructs to guide fast angiogenesis." 
Biomacromolecules 13(10): 3262-3271. 
Hakkinen, K. M., J. S. Harunaga, A. D. Doyle and K. M. Yamada (2011). "Direct 
comparisons of the morphology, migration, cell adhesions, and actin cytoskeleton of 
fibroblasts in four different three-dimensional extracellular matrices." Tissue Eng Part A 
17(5-6): 713-724. 
Hamilton, D. W., B. Chehroudi and D. M. Brunette (2007). "Comparative response of 
epithelial cells and osteoblasts to microfabricated tapered pit topographies in vitro and in 
vivo." Biomaterials 28(14): 2281-2293. 
Hering, T. M., J. Kollar, T. D. Huynh and J. B. Varelas (1996). "Purification and 
characterization of decorin core protein expressed in Escherichia coli as a maltose-
binding protein fusion." Anal Biochem 240: 98-108. 
Hill, S. J. and J. L. Ebersole (1996). "The effect of lipoplysaccharide on growth factor-
induced mitogensis in human gingival fibroblasts." J Periodontol 67: 1274-1280. 
Hinz, B. and G. Gabbiani (2010). "Fibrosis: recent advances in myofibroblast biology 
and new therapeutic perspectives." F1000 Biol Rep 2: 78. 
Humphreys, B. D., S. L. Lin, A. Kobayashi, T. E. Hudson, B. T. Nowlin, J. V. Bonventre, 
M. T. Valerius, A. P. McMahon and J. S. Duffield (2010). "Fate tracing reveals the 
137 
 
 
pericyte and not epithelial origin of myofibroblasts in kidney fibrosis." Am J Pathol 
176(1): 85-97. 
Hwang, C. M., Y. Park, J. Y. Park, K. Lee, K. Sun, A. Khademhosseini and S. H. Lee 
(2009). "Controlled cellular orientation on PLGA microfibers with defined diameters." 
Biomed Microdevices 11(4): 739-746. 
Kanda, T., N. Funato, Y. Baba and T. Kuroda (2003). "Evidence for fibroblast growth 
factor receptors in myofibroblasts during palatal mucoperiosteal repair." Archives of Oral 
Biology 48(3): 213-221. 
Karring, T., S. Nyman, J. Gottlow and L. Laurell (2000). "Development of the biological 
concept of guided tissue regeneration - animal and human studies." Periodontology 2000 
1: 26-35. 
Kocgozlu, L., R. Elkaim, H. Tenenbaum and S. Werner (2009). "Variable cell responses 
to P. gingivalis lipopolysaccharide." J Dent Res 88(8): 741-745. 
Liu, Y., Y. Ji, K. Ghosh, R. A. Clark, L. Huang and M. H. Rafailovich (2009). "Effects of 
fiber orientation and diameter on the behavior of human dermal fibroblasts on 
electrospun PMMA scaffolds." J Biomed Mater Res A 90(4): 1092-1106. 
Lowery, J. L., N. Datta and G. C. Rutledge (2010). "Effect of fiber diameter, pore size 
and seeding method on growth of human dermal fibroblasts in electrospun poly(epsilon-
caprolactone) fibrous mats." Biomaterials 31(3): 491-504. 
Mann, B. K., A. T. Tsai, T. Scott-Burden and J. L. West (1999). "Modification of 
surfaces with cell adhesion peptides alters extracellular matrix deposition." Biomaterials 
20: 2281-2286. 
Moore, W. E. C. and L. H. Moore (1994). "The bacteria of periodontal diseases." 
Periodontology 2000 5: 66-77. 
Ng, K. W., D. T. W. Leong and D. W. Hutmacher (2005). "The challenge to measure cell 
proliferation in two and three dimensions." Tissue Eng 11(1-2): 182-191. 
Oda, Y., H. Kagami and M. Ueda (2004). "Accelerating effects of basic fibroblast growth 
factor on wound healing of rat palatal mucosa." J Oral Maxofac Surg 62: 73-80. 
Polimeni, G., A. V. Xiropaidis and U. M. E. Wikesjo (2006). "Biology and principles of 
periodontal wound healing/regeneration." Periodontology 2000 41: 30-47. 
Potts, J. R. and I. D. Campbell (1994). "Fibronectin structure and assembly." Curr Opin 
Cell Biol 6: 648-655. 
Rampichova, M., J. Chvojka, M. Buzgo, E. Prosecka, P. Mikes, L. Vyslouzilova, D. 
Tvrdik, P. Kochova, T. Gregor, D. Lukas and E. Amler (2013). "Elastic three-
dimensional poly (epsilon-caprolactone) nanofibre scaffold enhances migration, 
138 
 
 
proliferation and osteogenic differentiation of mesenchymal stem cells." Cell Prolif 
46(1): 23-37. 
Reddy, G. K. and C. S. Enwemeka (1996). "A simplified method for the analysis of 
hydroxyproline in biological tissues." Clinical Biochemistry 29(3): 225-229. 
Schroeder, H. E. and M. A. Listgarten (1997). "The gingival tissues: the architecture of 
periodontal protection." Periodontology 2000 13: 91-120. 
Shang, S., F. Yang, X. Cheng, X. F. Walboomers and J. A. Jansen (2010). "The effect of 
electrospun fibre alignment on the behaviour of rat periodontal lligament cells." Eur Cell 
Mater 19: 180-192. 
Shi, H. X., C. Lin, B. B. Lin, Z. G. Wang, H. Y. Zhang, F. Z. Wu, Y. Cheng, L. J. Xiang, 
D. J. Guo, X. Luo, G. Y. Zhang, X. B. Fu, S. Bellusci, X. K. Li and J. Xiao (2013). "The 
anti-scar effects of basic fibroblast growth factor on the wound repair in vitro and in 
vivo." PLoS One 8(4): e59966. 
Streuli, C. (1999). "Extracellular matrix remodelling and cellular differentiation." Curr 
Opin Cell Biol 11: 634-640. 
Sun, H. H., T. J. Qu, X. H. Zhang, Q. Yu and F. M. Chen (2012). "Designing 
biomaterials for in situ periodontal tissue regeneration." Biotechnol Prog 28(1): 3-20. 
Takahashi, N. (2005). "Microbial ecosystem in the oral cavity: Metabolic diversity in an 
ecological niche and its relationship with oral diseases." International Congress Series 
1284: 103-112. 
Tan, Y., J. Xiao, Z. Huang, Y. Xiao, S. Lin, L. Jin, W. Feng, L. Cai and X. Li (2008). 
"Comparison of the therapeutic effects recombinant human acidic and basic fibroblast 
growth factors in wound healing in diabetic patients." Journal of Health Science 54(4): 
432-440. 
Wang, P. L. and K. Ohura (2002). "Porphyromonas gingivalis lipopolysaccharide 
signaling in gingival fibroblasts-CD14 and Toll-like receptors." Crit Rev Oral Biol Med 
13(2): 132-142. 
Wikesjo, U. M. E., W. H. Lim, R. C. Thomson and W. R. Hardwick (2003). "Periodontal 
repair in dogs: gingival tissue occlusion, a critical requirement for GTR?" J Clin 
Periodontol 30: 655-664. 
 
 
 
139 
 
 
 
 
 
 
 
 
 
Appendix and Curriculum Vitae 
 
 
  
140 
 
 
 
Appendix A: Animal protocol approval. 
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Appendix B: Human ethics approval. 
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Appendix C: Fibronectin immunoreactivity on the scaffold surface at low 
magnification.  
The secretion and deposition of the structural ECM protein fibronectin was visualized 
with immunocytochemistry; fibronectin (green), nuclei (blue).  No fibronectin deposition 
is evident at 6 hours of culture for all three scaffold types.  Fibronectin deposition 
becomes evident after 3 days of culture and remains visible after 7 days of culture.   
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Appendix D: No primary antibody negative control fibronectin 
immunofluorescence. 
The secretion and deposition of the structural ECM protein fibronectin was visualized 
with immunocytochemistry; fibronectin (green), nuclei (blue).  Negative control images 
in which no primary antibody was added were used to set the threshold value for 
fibronectin fluorescence.  A) Low magnification negative control images.  B) High 
magnification negative control images. 
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Appendix E: Biglycan immunoreactivity on the scaffold surface at low 
magnification. 
The production of the ECM proteoglycan biglycan was visualized with 
immunocytochemistry; biglycan (green), nuclei (blue).  Minimal biglycan 
immunoreactivity is detected at 6 hours of culture for all three scaffold types.  
Intracellular biglycan becomes evident by 3 days on all three scaffold types and appears 
diminished in the presence of bFGF release.   Intracellular biglycan immunoreactivity is 
also observed at 7 days.   
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Appendix F: No primary antibody negative control biglycan immunofluorescence. 
The production of the ECM proteoglycan biglycan was visualized with 
immunocytochemistry; biglycan (green), nuclei (blue).  Negative control images in which 
no primary antibody was added were used to set the threshold value for biglycan 
fluorescence.  A) Low magnification negative control images.  B) High magnification 
negative control images. 
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Appendix G: Decorin immunoreactivity on the scaffold surface at low 
magnification. 
The production of the small ECM proteoglycan decorin was visualized with 
immunocytochemistry; decorin (green), nuclei (blue).  Decorin immunoreactivity is 
observed on all three scaffold types at 6 hours.  Decorin is observed on all three scaffold 
types at day 3 however appears less prominent on the PCL alone scaffold.  Decorin 
appears localized to the cells after 7 days of culture. 
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Appendix H: No primary antibody negative control decorin immunofluorescence. 
The production of the ECM proteoglycan decorin was visualized with 
immunocytochemistry; decorin (green), nuclei (blue).  Negative control images in which 
no primary antibody was added were used to set the threshold value for decorin 
fluorescence.  A) Low magnification negative control images.  B) High magnification 
negative control images. 
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Appendix I: Influence of PCL electrospun scaffolds loaded with bFGF on decorin 
and versican mRNA levels. 
hGFs were seeded and cultured on PCL electrospun fibrous scaffolds with and without 
bFGF microspheres for 1, 7 or 14 days.  RNA was isolated and qRT-PCR was performed 
using primers specific for decorin (DCN, Hs00754870_s1) and versican (VCAN, 
HS00171642_m1).  mRNA levels were normalized to endogenous 18S ribosomal RNA 
levels.  A) Release of bFGF from the microspheres did not significantly alter the levels of 
decorin mRNA from that of the PCL alone scaffold.  Decorin mRNA expression levels 
showed a significant increase at 14 days on all scaffolds suggesting that decorin mRNA 
expression is time dependent rather than bFGF dependent.  B) Release of bFGF from the 
microspheres significantly increased the level of versican mRNA expression at 14 days of 
culture.  Data are presented as mean ± SD of three independent experiments.  Two-way 
ANOVA with Bonferroni’s post-test was used to compare means.   *p<0.05, **p<0.01, 
#p<0.001. 
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Appendix J: Collagen deposition in uninjured rat gingiva and immediately 
following gingivectomy. 
A) Van Gieson’s stain showing collagen (bright pink) in rat gingival tissue immediately 
after gingivectomy.  B) Van Gieson’s stain showing collagen (bright pink) in unwounded, 
healthy rat gingival tissue.  C) Masson’s trichrome stain showing collagen (blue) in rat 
gingival tissue immediately after gingivectomy.  D) Masson’s trichrome stain showing 
collagen (blue) in unwounded, healthy rat gingival tissue.   
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Appendix K: Myofibroblast population following in vivo gingivectomy.  
Gingivectomy was performed in a rat model and defects were treated with scaffold 
membranes of PCL alone, low bFGF loaded, high bFGF loaded or no treatment (empty 
defect).  Sections were labelled with a primary antibody for α-SMA and visualized with 
DAB staining.  A) Low magnification images.  Scale bar = 200 µm. B) High 
magnification images of the areas indicated by black boxes in A).  Scale bar = 100 µm. 
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Appendix L: No primary antibody negative control immunohistochemistry. 
Negative control images in which no primary antibody was added were used to set the 
threshold value for fluorescence in rat gingival wound sections.  A) Negative control 
image for arginase I immunofluorescence (cyan).  B) Negative control image for α-SMA 
immunofluorescence (red).  C) Negative control image for PCNA immunofluorescence 
(red).  D) Negative control image for α-SMA immunohistochemistry.  Scale bar = 200 
µm.   
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